Profiles
Luke Bereznicki
Luke Bereznicki
Professor of Pharmacy Practice
Pharmacy Building , Sandy Bay Campus
Overcrowded hospitals and packed emergency rooms are making headlines around the country. It’s a big problem that, despite our best efforts, is continuing to grow. With an ageing population, if we don’t do something about it, the strain on our hospitals is going to get worse. Preventing hospital admissions has never been so important.
Society is changing, and so is the way medication is used. People are living longer, so the number of medications that people are taking regularly has increased. In the older age groups, chronic diseases are more prevalent. These patients are at a higher risk of experiencing medication-related problems, which include adverse drug reactions (ADRs) or side effects that occur more frequently when patients take multiple medications. While many ADRs are minor in nature, they can also be very serious and lead to hospitalisation. Unplanned admissions in the elderly are becoming a huge burden on our health system. But, encouragingly, most of these admissions are preventable.
How do we identify people at risk of ADRs, so we can intervene before an episode occurs?
Professor Luke Bereznicki is a pharmacist whose research is focused on preventing ADR-related hospital admissions in the elderly. In fact, he and his team are testing a potential solution.
‘Our research shows that in people aged 65 and over, around 15-20 per cent of hospital admissions are associated with ADRs (side effects) of their medications,’ says Professor Bereznicki. ‘About 80-90 per cent of these admissions were preventable.’
Combinations of cardiovascular medications are most commonly implicated. The challenge is that these medications are often prescribed appropriately to manage a range of conditions, but sometimes the medications have additive effects that lead to problems.
‘For example, a patient could be on multiple medications, become dizzy, and then fall and hurt themselves. When we look at those admissions, there are elements there we could prevent through better medication management. In some instances, medications might not be necessary, or we could have monitored the patient more closely.
‘Our data shows us that the number of ADR admissions reported within the public health system are just the tip of the iceberg,’ says Professor Bereznicki. ‘The coding system in hospitals means that, often, ADR-related admissions are not recorded as such. The type of drug-related problems that are not being identified during the hospital admission are typically the ones that relate to combinations of medication. And, they’re much more common. In our recent study, only 1 in 5 ADR-related admissions that we identified were recorded by the hospital as ADRs.’
Professor Bereznicki and his team looked at a year of admissions to the Royal Hobart Hospital, focusing purely on overnight stays in medication wards. This research has helped them identify risk factors and use this information to develop a prediction score. This scoring system is called the Preventing Adverse Drug Reactions in Elderly Community Dwelling Patients (PADR-EC) Score.
‘Though we started in hospital with the admission, we focused on what happened to the patient before the admission – the factors that put them in hospital in the first place,’ explains Professor Bereznicki. ‘This hasn’t been done before, which is what makes our risk score novel.
‘Ultimately, we’re trying to create a risk profile for the patient and suggesting interventional strategies during the admission and following discharge. We will be developing a medication management plan for patients, which will be sent directly to their GP and pharmacist. This plan will focus on reducing the risk of serious ADRs.’
Elderly patients are often seeing a GP who can prescribe, a pharmacist who can prescribe over-the-counter medicines, and a specialist who prescribes different drugs again. It’s easy for patients to become confused about what they should be taking.
‘Someone has to put it all together and make sure we are reducing the risk of medication-related problems, while maximising the benefits of the medications required. To me, that’s our professional calling. Dispensing medication is an opportunity to review the effectiveness and safety of a patient’s medications.
‘Targeting high risk patients and improving their outcomes through a range of interventions, that’s what I would call “pure” clinical pharmacy. Improving medication safety is at the core of pharmacy practice and is the focus of our pharmacy degree at UTAS.’
Professor Luke Bereznicki is a pharmacist with 12 years experience working in the health care sector, and has been an academic at the University of Tasmania since 2007. His career is dedicated to improving pharmacy practice in Australia through learning and teaching, research and advocacy.
Biography
Luke graduated from the University of Tasmania's Discipline of Pharmacy in 2002 with first class honours. In 2003, he was an inaugural recipient of a National Institute of Clinical Studies (now part of the NHMRC) PhD Scholarship. His research program was focused on the implementation of strategies to improve the quality use of anticoagulants in the hospital and community settings. He was appointed at the University of Tasmania's Pharmacy in 2007 and is currently Professor in Pharmacy Practice. He is recognised as a leader in Australian pharmacy practice research and education, and has received a number of recent local and national awards recognising his work. He is dedicated to improving pharmacy practice in Australia through education, research and advocacy and was the 2008 Australian Young Pharmacist of the Year. In addition to his teaching and research activities, Luke is actively engaged in professional pharmacy practice; he works regularly in community pharmacy, writes regularly for the Australian Pharmacist and performs medication reviews and consultant pharmacist activities.
Luke's research has featured the implementation and evaluation of pharmacist involvement in a variety of quality improvement activities in both hospital and community settings. He is now recognised as one of the leading Australian authorities in this area and frequently speaks at conferences and provides education and training for health professionals and consumers. His research has been recognised nationally and internationally, and has resulted in a number of awards, including the following:
- Inaugural National Institute of Clinical Studies PhD Scholarship (2004-2007)
- Inaugural National Prescribing Service Student Quality Use of Medicine Award (2006)
- Tasmanian and Australian Pearcey Award for Innovative and Pioneering Achievement and Contribution to Research and Development in Information Technology (2006)
- Tasmanian Young Achiever in Science and Technology (2007) Dean of Graduate Research, (University of Tasmania)
- Commendation for an outstanding doctoral thesis (2008)
- Pharmaceutical Society of Australia Young Pharmacist of the Year (2008), Faculty of Health, University of Tasmania Rising Star (2009)
- University of Tasmania Rising Star (2010)
Luke has published over 180 original and professional peer-reviewed papers and attracted over $13 million in competitive funding. Luke has strong links with the pharmacy profession and is a longstanding member of the Tasmanian Branch Committee of the Pharmaceutical Society of Australian (Tasmanian Branch) and former Board Director of the organisation.
Memberships
Committee associations
- Chair, Scientific Advisory Committee, Australasian Pharmaceutical Science Association (2014-2015)
Former roles
- Board Director, Pharmaceutical Society of Australia (2011-2015)
- National Chair, Practice Support and Education Committee (PSEC), Pharmaceutical Society of Australia (2014-2015)
- National Chair, Accredited Pharmacists Special Interest Group, Pharmaceutical Society of Australia (2011-2014)
- Reference Group, Australian Government Review of Anticoagulant Therapies in Atrial Fibrillation (2011-2012)
- Pharmaceutical Society of Australia (Tasmanian Branch) Committee Vice-President (2008-2013)
- Pharmacy Board of Tasmania Graduate Accreditation Committee (2007-2009)
- Pharmacy Board of Tasmania Competency Committee (2007-2009)
Other
Luke is currently a peer-reviewer for the following international journals:
- Journal of Pharmacy Practice Research
- Journal of Clinical Pharmacy and Therapeutics
- Hematology
- International Journal of General Medicine
- Medical journal of Australia
- Journal of Medical Internet Research
Teaching
Teaching expertise
Luke teaches a diverse range of topics related to pharmacy practice including ethics, law, quality use of medicines, communication, non-prescription medicines and the identification and resolution of drug-related problems. He currently coordinates the honours program within the Division of Pharmacy, and teaches into pharmacy practice and research methodology units.
Luke has demonstrated a strong commitment to research training and leadership through Research Higher Degree (RHD) supervision, mentoring of academics and the development of research curricula and processes. He has supervised RHD students through to completion. He also supervises a number of honours students each year.
Teaching responsibility
Luke commenced teaching at Pharmacy in 2007, and is now Professor in Pharmacy Practice, Head (Pharmacy) and Deputy Head of the School of Medicine. He teaches a diverse range of topics related to pharmacy practice including ethics, law, quality use of medicines, communication, non-prescription medicines and the identification and resolution of drug-related problems. He is also the Honours Co-ordinator.
View more on Professor Luke Bereznicki in WARP
Expertise
Associate Professor Bereznicki leads a group of researchers and students focused on improving the quality of anticoagulant use in primary and tertiary care settings. He has been committed to improving the use and management of anticoagulants in Australia since his early career. He also has a range of other research interests which share a common focus on improving medication safety and preventing adverse drug events.
Luke's research has had a major impact on shaping the future of his profession and improving the quality use of medicines. He has led a range of research projects related to this theme, focussing on improving the management of a broad range of diseases, including respiratory disease, HIV, hypertension, acute coronary syndrome, pain and chronic kidney disease. He also leads a team of researchers and students focussed on the prevention of adverse drug events leading to hospitalisation.
Luke has extensive experience in the following major research areas:
- Clinical research
- Implementation research
- Clinical trials
- Anticoagulation management
- Pharmacy practice
- Medication adherence
- Chronic disease management
Research Themes
Luke leads a group of researchers and students focused on improving the quality of anticoagulant use in primary and tertiary care settings. He has been committed to improving the use and management of anticoagulants in Australia since his early career. He also has a range of other research interests which share a common focus on improving medication safety and preventing adverse drug events.
Luke's research has had a major impact on shaping the future of his profession and improving the quality use of medicines, and is strongly aligned to the University's research theme of Better Health. He has led a range of research projects related to this theme, focussing on improving the management of a broad range of diseases, including respiratory disease, HIV, hypertension, acute coronary syndrome, pain, chronic kidney disease. He also leads a team of researchers and students focussed on the prevention of adverse drug events leading to hospitalisation.
Luke has been a Chief Investigator on several major national projects that have investigated and implemented new professional activities for Australian pharmacists. He was recently a lead investigator on a number of national projects (> $1.5M) funded by the Department of Health and Ageing which aimed to evaluate the role of pharmacists in providing education, support and ongoing monitoring for people taking anticoagulants in the community. He developed and maintains anticoagulation.com.au, a site that provides free educational resources about anticoagulant medications to consumers and health professionals.
Luke has an outstanding national reputation for his contributions within multidisciplinary research and quality improvement teams. The collective impact of his research and leadership in his field is evidenced by invitations to present at national and international conferences.
A major focus of his work has been on strategies to improve the quality use of anticoagulant medications in the elderly via a range of innovative strategies. These projects have focussed on both the community dwelling and institutionalised elderly. He has published widely in local and international journals on this topic. His innovative research in anticoagulation management is internationally recognised. His status within the field of anticoagulant medication research was acknowledged by appointment to the Commonwealth Government reference group on the 2012 Review of Anticoagulant Therapies in Atrial Fibrillation, which preceded the PBS-listing of novel anticoagulant medications for the prevention of stroke in AF in late-2013.
Luke currently leads the Tasmanian Atrial Fibrillation Study, which is investigating the use anticoagulant medications to prevent stroke in Tasmanians with Atrial Fibrillation from 2011 onwards. While research involving antithrombotic medications has been his major focus, Luke has also been involved in a number of other projects focused on improving the quality use of medicines in community and hospital settings. Other current areas of interest include the management of respiratory diseases, prevention of adverse drug reactions, pain management and medication adherence in a range of chronic conditions.
Awards
- Inaugural National Prescribing Service Student Quality Use of Medicine Award (2006)
- Tasmanian and Australian Pearcey Award for Innovative and Pioneering Achievement and
- Contribution to Research and Development in Information Technology (2006)
- Tasmanian Young Achiever in Science and Technology (2007)* Pharmaceutical Society of Australia Young Pharmacist of the Year (2008)
- University of Tasmania Rising Star (2010)
Fields of Research
- Clinical pharmacy and pharmacy practice (321403)
- Pharmaceutical sciences (321405)
- Clinical pharmacology and therapeutics (321402)
- Health services and systems (420399)
- Basic pharmacology (321401)
- Cardiology (incl. cardiovascular diseases) (320101)
- Pharmacology and pharmaceutical sciences (321499)
- Respiratory diseases (320103)
- Health and community services (420305)
- Preventative health care (420605)
- Haematology (320102)
- Health informatics and information systems (420308)
- Primary health care (420319)
- Aged health care (420301)
- Paediatrics (321399)
- Cardiovascular medicine and haematology (320199)
- Residential client care (420320)
- Medicine, nursing and health curriculum and pedagogy (390110)
- Health promotion (420603)
- Health counselling (420307)
- Health care administration (420306)
- Higher education (390303)
- Nephrology and urology (320214)
- Traditional, complementary and integrative medicine (420899)
- Community child health (420601)
- Aboriginal and Torres Strait Islander public health and wellbeing (450417)
- Community and primary care (420503)
- Geriatrics and gerontology (320210)
- Infant and child health (321302)
- Pathology (excl. oral pathology) (320220)
- Intensive care (320212)
- Pharmacogenomics (321406)
- Oncology and carcinogenesis (321199)
- Orthopaedics (320216)
- Rheumatology and arthritis (320223)
- Public health nutrition (321005)
- Medical biochemistry and metabolomics (320599)
- Toxicology (incl. clinical toxicology) (321407)
- Service oriented computing (460612)
- Infectious diseases (320211)
- Orthodontics and dentofacial orthopaedics (320308)
- Clinical sciences (320299)
- Pain (320218)
- Acute care (420501)
Research Objectives
- Other health (209999)
- Clinical health (200199)
- Diagnosis of human diseases and conditions (200101)
- Evaluation of health outcomes (200202)
- Preventive medicine (200412)
- Health education and promotion (200203)
- Health related to ageing (200502)
- Evaluation of health and support services (200299)
- Expanding knowledge in the health sciences (280112)
- Neonatal and child health (200506)
- Treatment of human diseases and conditions (200105)
- Allied health therapies (excl. mental health services) (200301)
- Human pain management (200103)
- Prevention of human diseases and conditions (200104)
- Efficacy of medications (200102)
- Behaviour and health (200401)
- Public health (excl. specific population health) (200499)
- Rural and remote area health (200508)
- Primary care (200310)
- Provision of health and support services (200399)
- Assessment, development and evaluation of curriculum (160301)
- Health policy evaluation (200205)
- Specific population health (excl. Indigenous health) (200599)
- Teaching and instruction technologies (160304)
- Learner and learning (160199)
- Nursing (200307)
- Other education and training (169999)
- Nutrition (200410)
- Men's health (200504)
- Other information and communication services (229999)
Publications
Total publications
357
Journal Article
(228 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2023 | Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Simpson T, et al., 'Impact of partnered pharmacist medication charting (PPMC) on medication discrepancies and errors: A pragmatic evaluation of an emergency department-based process redesign', International Journal of Environmental Research and Public Health, 20, (2) pp. 1-15. ISSN 1660-4601 (2023) [Refereed Article] DOI: 10.3390/ijerph20021452 [eCite] [Details] Co-authors: Atey TM; Peterson GM; Salahudeen MS; Burgess JR; Tran V; Wimmer BC | |
| 2023 | Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Simpson T, et al., 'Impact of Partnered Pharmacist Medication Charting (PPMC) on Medication Discrepancies and Errors: A Pragmatic Evaluation of an Emergency Department-Based Process Redesign', International Journal of Environmental Research and Public Health, 20, (2) Article 1452. ISSN 1660-4601 (2023) [Refereed Article] DOI: 10.3390/ijerph20021452 [eCite] [Details] Co-authors: Atey TM; Peterson GM; Salahudeen MS; Burgess John; Tran V; Wimmer BC | |
| 2023 | Lartey ST, Lung T, Serhal S, Bereznicki L, Bereznicki B, et al., 'Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma', PLoS One, 18, (1) Article e0279748. ISSN 1932-6203 (2023) [Refereed Article] DOI: 10.1371/journal.pone.0279748 [eCite] [Details] Co-authors: Bereznicki B | |
| 2022 | Ali S, Curtain C, Bereznicki LRE, Salahudeen MS, 'Actual drug-related harms in residential aged care facilities: a narrative review', Expert Opinion on Drug Safety, 21, (8) pp. 1047-1060. ISSN 1474-0338 (2022) [Refereed Article] DOI: 10.1080/14740338.2022.2084071 [eCite] [Details] Co-authors: Ali S; Curtain C; Salahudeen MS | |
| 2022 | Atey T, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer BC, 'Impact of pharmacist interventions provided in the emergency department on quality use of medicines: a systematic review and meta-analysis', Emergency Medicine Journal, 40 pp. 120-127. ISSN 1472-0205 (2022) [Refereed Article] DOI: 10.1136/emermed-2021-211660 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Atey T; Peterson GM; Salahudeen MS; Wimmer BC | |
| 2022 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study', Journal of the American Heart Association, 11, (7) Article e023098. ISSN 2047-9980 (2022) [Refereed Article] DOI: 10.1161/JAHA.121.023098 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM | |
| 2022 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants', Expert Review of Clinical Pharmacology, 15, (3) pp. 359-364. ISSN 1751-2433 (2022) [Refereed Article] DOI: 10.1080/17512433.2022.2070151 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Salahudeen MS; Bindoff I; Peterson GM | |
| 2022 | Jatau Abubakar I, Bereznicki LR, Wimmer BC, Bezabhe WM, Peterson GM, 'Improving knowledge and early detection of atrial fibrillation through a community-based opportunistic screening program: what's your beat?', International Journal of Environmental Research and Public Health, 19, (11) Article 6860. ISSN 1661-7827 (2022) [Refereed Article] DOI: 10.3390/ijerph19116860 [eCite] [Details] Co-authors: Wimmer BC; Bezabhe WM; Peterson GM | |
| 2022 | Kefale AT, Peterson GM, Bezabhe WM, Bereznicki LR, 'Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data', Expert Review of Clinical Pharmacology, 15, (3) pp. 351-357. ISSN 1751-2433 (2022) [Refereed Article] DOI: 10.1080/17512433.2022.2044793 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Kefale AT; Peterson GM; Bezabhe WM | |
| 2022 | Mirkazemi C, Williams M, Berbecaru M, Stubbings T, Murray S, et al., 'Practising pharmacists want more nutrition education', Currents in Pharmacy Teaching and Learning, 14, (11) pp. 1420-1430. ISSN 1877-1297 (2022) [Refereed Article] DOI: 10.1016/j.cptl.2022.09.024 [eCite] [Details] Co-authors: Mirkazemi C; Williams M; Berbecaru M; Murray S; Veal F; Cooper N | |
| 2022 | Roughead EE, Pratt NL, Parfitt G, Rowett D, Kalisch-Ellett LM, et al., 'Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)', Age and Ageing, 51, (4) Article afac092. ISSN 0002-0729 (2022) [Refereed Article] DOI: 10.1093/ageing/afac092 [eCite] [Details] Citations: Scopus - 2Web of Science - 3 Co-authors: Cousins J; Williams M | |
| 2022 | Schmid O, Bereznicki B, Peterson GM, Stankovich J, Bereznicki L, 'Persistence of Adverse drug reaction-related hospitalization risk following discharge', International journal of environmental research and public health, 9, (19) Article 5585. ISSN 1660-4601 (2022) [Refereed Article] DOI: 10.3390/ijerph19095585 [eCite] [Details] Co-authors: Schmid O; Bereznicki B; Peterson GM; Stankovich J | |
| 2022 | Serhal S, Armour C, Billot L, Krass I, Emmerton L, et al., 'Integrating pharmacy and registry data strengthens clinical assessments of patient adherence', Frontiers in Pharmacology, 13 Article 869162. ISSN 1663-9812 (2022) [Refereed Article] DOI: 10.3389/fphar.2022.869162 [eCite] [Details] Co-authors: Bereznicki B | |
| 2022 | Serhal S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, et al., 'Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review', n p j Primary Care Respiratory Medicine Article 53. ISSN 2055-1010 (2022) [Refereed Article] DOI: 10.1038/s41533-022-00315-6 [eCite] [Details] Co-authors: Bereznicki B | |
| 2022 | Serhal S, Mitchell B, Krass I, Emmerton L, Bereznicki B, et al., 'Rethinking the gold standard - The feasibility of randomized controlled trials within health services effectiveness research', Research in social & administrative pharmacy : RSAP, 18, (9) pp. 3656-3668. ISSN 1551-7411 (2022) [Refereed Article] DOI: 10.1016/j.sapharm.2022.03.017 [eCite] [Details] Co-authors: Bereznicki B | |
| 2022 | Serhal S, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al., 'Pharmacist-delivered asthma management services - what do patients think?', Journal of the American Pharmacists Association, 62, (4) pp. 1260-1269. ISSN 1544-3191 (2022) [Refereed Article] DOI: 10.1016/j.japh.2022.02.009 [eCite] [Details] Co-authors: Bereznicki B; Wilson K | |
| 2022 | Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton E, et al., 'A novel multi-mode education program to enhance asthma care by pharmacists', American journal of pharmaceutical education, 86, (4) Article 8633. ISSN 0002-9459 (2022) [Refereed Article] DOI: 10.5688/ajpe8633 [eCite] [Details] Citations: Scopus - 1Web of Science - 3 Co-authors: Bereznicki B; Wilson K | |
| 2022 | Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia', Therapeutic Advances in Drug Safety, 13 pp. 1-9. ISSN 2042-0994 (2022) [Refereed Article] DOI: 10.1177/20420986221080796 [eCite] [Details] Citations: Scopus - 3Web of Science - 2 Co-authors: Zaidi AS; Peterson GM; Curtain CM; Salahudeen MS | |
| 2021 | Ali S, Salahudeen MS, Bereznicki LRE, Curtain CM, 'Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: a systematic review', British Journal of Clinical Pharmacology ISSN 0306-5251 (2021) [Refereed Article] DOI: 10.1111/bcp.14824 [eCite] [Details] Citations: Scopus - 11Web of Science - 12 Co-authors: Ali S; Salahudeen MS; Curtain CM | |
| 2021 | Bezabhe WM, Bereznicki LR, Radford J, Salahudeen MS, Garrahy E, et al., 'Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation', Internal Medicine Journal, 51, (10) pp. 1732-1735. ISSN 1444-0903 (2021) [Refereed Article] DOI: 10.1111/imj.15514 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: Bezabhe WM; Radford J; Salahudeen MS; Garrahy E; Wimmer BC; Bindoff I; Peterson GM | |
| 2021 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Curtain C, et al., 'Ten-Year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation', Frontiers in Pharmacology, 12 Article 586370. ISSN 1663-9812 (2021) [Refereed Article] DOI: 10.3389/fphar.2021.586370 [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM | |
| 2021 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up', European Journal of Clinical Investigation Article e13489. ISSN 0014-2972 (2021) [Refereed Article] DOI: 10.1111/eci.13489 [eCite] [Details] Citations: Scopus - 8Web of Science - 10 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM | |
| 2021 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Eight-year trends in direct-acting oral anticoagulant dosing, based on age and kidney function, in patients with atrial fibrillation', Journal of Patient Safety pp. 1-5. ISSN 1549-8417 (2021) [Refereed Article] DOI: 10.1097/PTS.0000000000000924 [eCite] [Details] Co-authors: Bezabhe WM; Radford J; Wimmer BC; Salahudeen MS; Peterson GM | |
| 2021 | Cousins J, Parameswaran Nair N, Curtain C, Bereznicki B, Wilson K, et al., 'Preventing adverse drug reactions after hospital discharge (PADR-AD): Protocol for a randomised-controlled trial in older people', Research in Social and Administrative Pharmacy ISSN 1934-8150 (2021) [Refereed Article] DOI: 10.1016/j.sapharm.2021.09.007 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Cousins J; Parameswaran Nair N; Curtain C; Bereznicki B; Wilson K | |
| 2021 | Gaffney GR, Bereznicki LR, Bereznicki BJ, 'Knowledge, beliefs and management of childhood fever among nurses and other health professionals: a cross-sectional survey', Nurse Education Today, 97 Article 104731. ISSN 0260-6917 (2021) [Refereed Article] DOI: 10.1016/j.nedt.2020.104731 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Gaffney GR; Bereznicki BJ | |
| 2021 | Gebreyohannes EA, Mill D, Salter S, Chalmers L, Bereznicki L, et al., 'Strategies for improving guideline adherence of anticoagulants for patients with atrial fibrillation in primary healthcare: A systematic review', Thrombosis Research, 205 pp. 128-136. ISSN 0049-3848 (2021) [Refereed Article] DOI: 10.1016/j.thromres.2021.07.014 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 | |
| 2021 | Gebreyohannes EA, Salter SM, Chalmers L, Bereznicki L, Lee K, 'Reasons for non-adherence to thromboprophylaxis prescribing guidelines in atrial fibrillation in Western Australia: a qualitative descriptive study of general practitioners' views', Thrombosis Research, 208 pp. 83-91. ISSN 0049-3848 (2021) [Refereed Article] DOI: 10.1016/j.thromres.2021.10.025 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 | |
| 2021 | Kefale AT, Peterson GM, Bezabhe WM, Bereznicki LR, 'Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review', British Journal of Clinical Pharmacology pp. 1-20. ISSN 0306-5251 (2021) [Refereed Article] DOI: 10.1111/bcp.15021 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Kefale AT; Peterson GM; Bezabhe WM | |
| 2021 | Ridge A, Macintyre K, Kitsos A, Murray L, Bereznicki L, 'Assessing risk of adverse drug reactions in the elderly: a feasibility study', International Journal of Clinical Pharmacy, 41, (6) pp. 1483-1490. ISSN 2210-7703 (2021) [Refereed Article] DOI: 10.1007/s11096-019-00908-1 [eCite] [Details] Citations: Scopus - 2 Co-authors: Ridge A; Macintyre K; Kitsos A; Murray L | |
| 2021 | Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, et al., 'A targeted approach to improve asthma control using community pharmacists', Frontiers in Pharmacology, 12 Article 798263. ISSN 1663-9812 (2021) [Refereed Article] DOI: 10.3389/fphar.2021.798263 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Co-authors: Bereznicki B; Wilson K | |
| 2020 | Bertilsson E, Serhal S, Emmerton L, Bosnic-Anticevich S, Krass I, et al., 'Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial', Research in Social and Administrative Pharmacy, 17, (3) pp. 595-605. ISSN 1934-8150 (2020) [Refereed Article] DOI: 10.1016/j.sapharm.2020.05.012 [eCite] [Details] Citations: Scopus - 3Web of Science - 4 Co-authors: Bereznicki B | |
| 2020 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Curtain C, et al., 'Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation', European Journal of Clinical Investigation, 51, (5) Article e13457. ISSN 0014-2972 (2020) [Refereed Article] DOI: 10.1111/eci.13457 [eCite] [Details] Citations: Scopus - 12Web of Science - 10 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM | |
| 2020 | Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Five-year trends in potential drug interactions with direct-acting oral anticoagulants in patients with atrial fibrillation: an Australian-wide study', Journal of Clinical Medicine, 9, (11) Article 3568. ISSN 2077-0383 (2020) [Refereed Article] DOI: 10.3390/jcm9113568 [eCite] [Details] Citations: Scopus - 10Web of Science - 11 Co-authors: Bezabhe WM; Radford J; Wimmer BC; Salahudeen MS; Bindoff I; Garrahy E; Peterson GM | |
| 2020 | Bezabhe WM, Kitsos A, Saunder T, Peterson GM, Bereznicki LR, et al., 'Medication prescribing quality in Australian primary care patients with chronic kidney disease', Journal of Clinical Medicine, 9, (3) Article 783. ISSN 2077-0383 (2020) [Refereed Article] DOI: 10.3390/jcm9030783 [eCite] [Details] Citations: Scopus - 8Web of Science - 5 Co-authors: Bezabhe WM; Kitsos A; Peterson GM; Wimmer BC; Jose M; Radford J | |
| 2020 | Curtain CM, Chang JY, Cousins J, Parameswaran Nair N, Bereznicki B, et al., 'Medication regimen complexity index prediction of adverse drug reaction-related hospital admissions', The Annals of Pharmacotherapy, 54, (10) Article 996-1000. ISSN 1060-0280 (2020) [Refereed Article] DOI: 10.1177/1060028020919188 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Curtain CM; Cousins J; Parameswaran Nair N; Bereznicki B | |
| 2020 | Ertl J, Chalmers L, Bereznicki L, 'The quality of advice provided by pharmacists to patients taking direct oral anticoagulants: a mystery shopper study', Pharmacy, 8, (3) Article 164. ISSN 2226-4787 (2020) [Refereed Article] DOI: 10.3390/pharmacy8030164 [eCite] [Details] Co-authors: Chalmers L | |
| 2020 | Gebreyohannes EA, Salter S, Chalmers L, Bereznicki L, Lee KJ, 'Non-adherence to thromboprophylaxis guidelines in Atrial fibrillation: a narrative review of the extent of and factors in guideline non-adherence', American Journal of Cardiovascular Drugs ISSN 1175-3277 (2020) [Refereed Article] DOI: 10.1007/s40256-020-00457-3 [eCite] [Details] Citations: Scopus - 7Web of Science - 9 Co-authors: Lee KJ | |
| 2020 | Jatau Abubakar I, Wimmer BC, Bereznicki LR, Dwan C, Black JA, et al., 'Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT)', International Journal of Environmental Research and Public Health, 17, (5) Article 1721. ISSN 1661-7827 (2020) [Refereed Article] DOI: 10.3390/ijerph17051721 [eCite] [Details] Citations: Scopus - 4Web of Science - 3 Co-authors: Wimmer BC; Dwan C; Bezabhe WM; Peterson GM | |
| 2020 | Lim R, Bereznicki LR, Corlis M, Kalisch Ellet LM, Kang AC, et al., 'Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome', BMJ open, 10, (4) Article e032851. ISSN 2044-6055 (2020) [Refereed Article] DOI: 10.1136/bmjopen-2019-032851 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Cousins J; Williams M | |
| 2020 | Pilcher SM, Alamneh EA, Chalmers L, Bereznicki LR, 'The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex', The Annals of Pharmacotherapy ISSN 1060-0280 (2020) [Refereed Article] DOI: 10.1177/1060028020904969 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Pilcher SM; Alamneh EA; Chalmers L | |
| 2020 | Veal F, Thompson A, Halliday S, Boyles P, Orlikowski C, et al., 'The Persistence of opioid use following surgical admission: an Australian single-site retrospective cohort study', Journal of Pain Research, 13 pp. 703-708. ISSN 1178-7090 (2020) [Refereed Article] DOI: 10.2147/JPR.S235764 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Veal F; Thompson A | |
| 2020 | Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis', The Annals of Pharmacotherapy, 55, (4) pp. 530-542. ISSN 1060-0280 (2020) [Refereed Article] DOI: 10.1177/1060028020949125 [eCite] [Details] Citations: Scopus - 2Web of Science - 3 Co-authors: Zaidi AS; Peterson GM; Curtain CM; Salahudeen MS | |
| 2019 | Ali S, Peterson GM, Bereznicki L, Salahudeen MS, 'Association between anticholinergic drug burden and mortality in older people: a systematic review', European Journal of Clinical Pharmacology, 76, (3) pp. 319-335. ISSN 0031-6970 (2019) [Refereed Article] DOI: 10.1007/s00228-019-02795-x [eCite] [Details] Citations: Scopus - 15Web of Science - 13 Co-authors: Peterson GM; Salahudeen MS | |
| 2019 | Jatau AI, Peterson GM, Bereznicki LRE, Dwan C, Black JA, et al., 'Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation', Clinical Medicine Insights: Cardiology, 13 pp. 1-8. ISSN 1179-5468 (2019) [Refereed Article] DOI: 10.1177/1179546819885134 [eCite] [Details] Citations: Scopus - 9Web of Science - 9 Co-authors: Peterson GM; Dwan C; Bezabhe W; Wimmer BC | |
| 2019 | Mirkazemi C, Bereznicki LR, Peterson GM, 'Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017', Bmc Musculoskeletal Disorders, 20, (1) pp. 1-11. ISSN 1471-2474 (2019) [Refereed Article] DOI: 10.1186/s12891-019-2409-3 [eCite] [Details] Citations: Scopus - 9Web of Science - 9 Co-authors: Mirkazemi C; Peterson GM | |
| 2019 | Veal F, Thompson A, Halliday S, Boyles P, Orlikowski C, et al., 'Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?', Emergency medicine Australasia pp. 1-5. ISSN 1742-6731 (2019) [Refereed Article] DOI: 10.1111/1742-6723.13442 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Veal F; Thompson A | |
| 2019 | Veal F, Williams M, Bereznicki L, Cummings E, Winzenberg T, 'A retrospective review of pain management in Tasmanian residential aged care facilities', BJGP Open, 3, (1) pp. 1-8. ISSN 2398-3795 (2019) [Refereed Article] DOI: 10.3399/bjgpopen18X101629 [eCite] [Details] Citations: Scopus - 3 Co-authors: Veal F; Williams M; Cummings E; Winzenberg T | |
| 2019 | Wertheimer G, Bereznicki LR, 'Exploring the quality of anticoagulant prescribed for patients with atrial fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia', Journal of cardiovascular pharmacology and therapeutics pp. 1-8. ISSN 1074-2484 (2019) [Refereed Article] DOI: 10.1177/1074248418786264 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 | |
| 2019 | Wilson KM, Beggs SA, Zosky GR, Bereznicki LR, Bereznicki BJ, 'Parental knowledge, beliefs and management of childhood fever in Australia: a nationwide survey', Journal of Clinical Pharmacy and Therapeutics, 44, (5) pp. 768-774. ISSN 0269-4727 (2019) [Refereed Article] DOI: 10.1111/jcpt.13000 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Co-authors: Wilson KM; Zosky GR; Bereznicki BJ | |
| 2018 | Admassie E, Chalmers L, Bereznicki LR, 'Thromboembolism and mortality in the Tasmanian Atrial Fibrillation Study', Journal of cardiovascular pharmacology and therapeutics, 23, (4) pp. 329-336. ISSN 1074-2484 (2018) [Refereed Article] DOI: 10.1177/1074248418769638 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Admassie E; Chalmers L | |
| 2018 | Angamo MT, Chalmers L, Curtain CM, Yilma D, Bereznicki L, 'Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study', Journal of Clinical Pharmacy and Therapeutics, 43, (6) pp. 790-798. ISSN 0269-4727 (2018) [Refereed Article] DOI: 10.1111/jcpt.12702 [eCite] [Details] Citations: Scopus - 9Web of Science - 8 Co-authors: Angamo MT; Chalmers L; Curtain CM | |
| 2018 | Bereznicki BJ, Tucker MGA, Beggs SA, Zosky GR, Bereznicki LRE, 'Emergency department presentations of febrile children to an Australian public hospital', Journal of Paediatrics and Child Health, 54, (12) pp. 1308-1313. ISSN 1034-4810 (2018) [Refereed Article] DOI: 10.1111/jpc.14071 [eCite] [Details] Citations: Scopus - 5Web of Science - 6 Co-authors: Bereznicki BJ; Zosky GR | |
| 2018 | Bereznicki LRE, 'An update on atrial fibrillation', Australian Pharmacist pp. 29-36. ISSN 0728-4632 (2018) [Professional, Refereed Article] | |
| 2018 | Frain B, Castelino R, Bereznicki LR, 'The utilization of antithrombotic therapy in older patients in aged care facilities with atrial fibrillation', Clinical and Applied Thrombosis/Hemostasis, 24, (3) pp. 519-524. ISSN 1076-0296 (2018) [Refereed Article] DOI: 10.1177/1076029616686421 [eCite] [Details] Citations: Scopus - 11Web of Science - 8 Co-authors: Frain B; Castelino R | |
| 2018 | Gheewala PA, Zaidi STR, Jose MD, Bereznicki L, Peterson GM, et al., 'Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review', Journal of Nephrology, 31, (1) pp. 27-36. ISSN 1724-6059 (2018) [Refereed Article] DOI: 10.1007/s40620-017-0375-0 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Gheewala PA; Zaidi STR; Jose MD; Peterson GM; Castelino RL | |
| 2018 | Li R, Curtain C, Bereznicki L, Zaidi STR, 'Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross‑sectional survey', International Journal of Clinical Pharmacy, 40, (4) pp. 878--889. ISSN 2210-7703 (2018) [Refereed Article] DOI: 10.1007/s11096-018-0700-2 [eCite] [Details] Citations: Scopus - 32Web of Science - 29 Co-authors: Li R; Curtain C; Zaidi STR | |
| 2018 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Adherence to oral anticoagulants in atrial fibrillation: an Australian survey', Journal of Cardiovascular Pharmacology and Therapeutics, 23, (4) pp. 337-343. ISSN 1074-2484 (2018) [Refereed Article] DOI: 10.1177/1074248418770201 [eCite] [Details] Citations: Scopus - 23Web of Science - 20 Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki BJ | |
| 2018 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LRE, 'Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey', International journal of clinical practice, 72, (3) Article e13072. ISSN 1368-5031 (2018) [Refereed Article] DOI: 10.1111/ijcp.13072 [eCite] [Details] Citations: Scopus - 18Web of Science - 21 Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki BJ | |
| 2018 | Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Curtain CM, et al., 'Prospective identification versus administrative coding of adverse drug reaction‐related hospitalizations in the elderly: a comparative analysis', Pharmacoepidemiology and Drug Safety, 27, (11) pp. 1281-1285. ISSN 1053-8569 (2018) [Refereed Article] DOI: 10.1002/pds.4667 [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Parameswaran Nair N; Chalmers L; Peterson GM; Bereznicki BJ; Curtain CM | |
| 2018 | Veal F, Williams M, Bereznicki L, Cummings E, Thompson A, et al., 'Barriers to optimal pain management in aged care facilities: an Australian qualitative study', Pain Management Nursing, 19, (2) pp. 1-9. ISSN 1524-9042 (2018) [Refereed Article] DOI: 10.1016/j.pmn.2017.10.002 [eCite] [Details] Citations: Scopus - 13Web of Science - 11 Co-authors: Veal F; Williams M; Cummings E; Thompson A; Peterson G; Winzenberg T | |
| 2018 | Veal FC, Thompson AJ, Perry LJ, Bereznicki LR, Peterson GM, 'Pain intensity and pain self-management strategies following discharge after surgery: An Australian prospective observational study', Journal of Clinical Pharmacy and Therapeutics, 43, (1) pp. 8-14. ISSN 0269-4727 (2018) [Refereed Article] DOI: 10.1111/jcpt.12584 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Veal FC; Thompson AJ; Peterson GM | |
| 2018 | Wright CM, Bezabhe W, Fitton JH, Stringer DN, Bereznicki LRE, et al., 'Effect of a fucoidan extract on insulin resistance and cardiometabolic markers in obese, nondiabetic subjects: a randomized, controlled trial', Journal of Alternative and Complementary Medicine, 25, (3) pp. 346-352. ISSN 1075-5535 (2018) [Refereed Article] DOI: 10.1089/acm.2018.0189 [eCite] [Details] Citations: Scopus - 11Web of Science - 12 Co-authors: Wright CM; Bezabhe W; Peterson GM | |
| 2017 | Admassie E, Chalmers L, Bereznicki LR, 'Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study', European Journal of Clinical Pharmacology, 73, (12) pp. 1681-1689. ISSN 0031-6970 (2017) [Refereed Article] DOI: 10.1007/s00228-017-2337-9 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Admassie E; Chalmers L | |
| 2017 | Admassie E, Chalmers L, Bereznicki LR, 'Changes in oral anticoagulant prescribing for stroke prevention in patients with atrial fibrillation', American Journal of Cardiology, 120, (7) pp. 1133-1138. ISSN 0002-9149 (2017) [Refereed Article] DOI: 10.1016/j.amjcard.2017.06.055 [eCite] [Details] Citations: Scopus - 25Web of Science - 25 Co-authors: Admassie E; Chalmers L | |
| 2017 | Alamneh EA, Chalmers L, Bereznicki LR, 'The Tasmanian Atrial Fibrillation Study: Transition to direct oral anticoagulants 2011-2015', Cardiovascular Therapeutics, 35, (3) Article e12254. ISSN 1755-5922 (2017) [Refereed Article] DOI: 10.1111/1755-5922.12254 [eCite] [Details] Citations: Scopus - 19Web of Science - 18 Co-authors: Alamneh EA; Chalmers L | |
| 2017 | Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L, 'Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study', PLoS One, 12, (10) Article e0186631. ISSN 1932-6203 (2017) [Refereed Article] DOI: 10.1371/journal.pone.0186631 [eCite] [Details] Citations: Scopus - 23Web of Science - 24 Co-authors: Angamo MT; Curtain CM; Chalmers L | |
| 2017 | Bereznicki B, Walters H, Walters J, Peterson G, Bereznicki L, 'Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face', Internal Medicine Journal, 47, (7) pp. 807-813. ISSN 1444-0903 (2017) [Refereed Article] DOI: 10.1111/imj.13418 [eCite] [Details] Citations: Scopus - 4Web of Science - 5 Co-authors: Bereznicki B; Walters H; Walters J; Peterson G | |
| 2017 | Bereznicki BJ, Chapman MP, Bereznicki LRE, 'Factors associated with overestimation of asthma control: a crosssectional study in Australia', Journal of Asthma, 54, (4) pp. 439-446. ISSN 1532-4303 (2017) [Refereed Article] DOI: 10.1080/02770903.2016.1226899 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Bereznicki BJ | |
| 2017 | Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Patient characteristics and antithrombotic prescribing patterns in patients with atrial fibrillation in Tasmania', Clinical and Applied Thrombosis - Hemostasis, 23, (5) pp. 438-444. ISSN 1076-0296 (2017) [Refereed Article] DOI: 10.1177/1076029615623375 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Bista D; Chalmers L; Peterson GM | |
| 2017 | Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?', Clinical and Applied Thrombosis/Hemostasis, 23, (6) pp. 573-578. ISSN 1076-0296 (2017) [Refereed Article] DOI: 10.1177/1076029616642511 [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Co-authors: Bista D; Chalmers L; Peterson GM | |
| 2017 | Cousins JM, Bereznicki LRE, Cooling NB, Peterson GM, 'Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey', Clinical Interventions in Aging, 12 pp. 1573-1578. ISSN 1178-1998 (2017) [Refereed Article] DOI: 10.2147/CIA.S146613 [eCite] [Details] Citations: Scopus - 13Web of Science - 12 Co-authors: Cousins JM; Cooling NB; Peterson GM | |
| 2017 | Frain BE, Castelino R, Bereznicki L, 'The utilization of antithrombotic therapy in older Australians with atrial fibrillation', Clinical and Applied Thrombosis/Hemostasis, 23, (6) pp. 671-676. ISSN 1076-0296 (2017) [Refereed Article] DOI: 10.1177/1076029616637184 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Frain BE; Castelino R | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, et al., 'Adverse drug reaction-related hospitalizations in elderly Australians: A prospective cross-sectional study in two Tasmanian hospitals', Drug Safety, 40, (7) pp. 597-606. ISSN 0114-5916 (2017) [Refereed Article] DOI: 10.1007/s40264-017-0528-z [eCite] [Details] Citations: Scopus - 32Web of Science - 25 Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain C; Peterson GM; Connolly M | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, et al., 'Authors' Reply to Mona Kargar and Colleagues' Comment on 'Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals'', Drug Safety pp. 1-2. ISSN 0114-5916 (2017) [Letter or Note in Journal] DOI: 10.1007/s40264-017-0613-3 [eCite] [Details] Citations: Web of Science - 3 Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain C; Peterson GM; Connolly M | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR, 'Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital', Drugs & Aging, 34, (10) ISSN 1170-229X (2017) [Refereed Article] DOI: 10.1007/s40266-017-0490-6 [eCite] [Details] Citations: Scopus - 15Web of Science - 15 Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain CM | |
| 2017 | Rolls CA, Obamiro KO, Chalmers L, Bereznicki LRE, 'The relationship between knowledge, health literacy and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation', Cardiovascular therapeutics, 35, (6) Article e12304. ISSN 1755-5914 (2017) [Refereed Article] DOI: 10.1111/1755-5922.12304 [eCite] [Details] Citations: Scopus - 35Web of Science - 35 Co-authors: Obamiro KO; Chalmers L | |
| 2017 | Veal FC, Thompson AJ, Bereznicki LRE, Peterson GM, 'Persistent pain management in Australian general practice', Australian Journal of Primary Health, 23 pp. 105-106. ISSN 1836-7399 (2017) [Letter or Note in Journal] DOI: 10.1071/PY16141 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Veal FC; Thompson AJ; Peterson GM | |
| 2016 | Alamneh EA, Chalmers L, Bereznicki LR, 'Suboptimal use of oral anticoagulants in atrial fibrillation: has the introduction of direct oral anticoagulants improved prescribing practices?', American Journal of Cardiovascular Drugs, 16, (3) pp. 183-200. ISSN 1175-3277 (2016) [Refereed Article] DOI: 10.1007/s40256-016-0161-8 [eCite] [Details] Citations: Scopus - 64Web of Science - 62 Co-authors: Alamneh EA; Chalmers L | |
| 2016 | Angamo MT, Chalmers L, Curtain CM, Bereznicki LRE, 'Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors', Drug Safety, 39, (9) pp. 847-857. ISSN 0114-5916 (2016) [Refereed Article] DOI: 10.1007/s40264-016-0444-7 [eCite] [Details] Citations: Scopus - 77Web of Science - 78 Co-authors: Angamo MT; Chalmers L; Curtain CM | |
| 2016 | Bereznicki LRE, Van Tienen EC, Stafford A, 'Home medicines reviews in Australian war veterans taking warfarin do not influence international normalised ratio control', Internal Medicine Journal, 46, (3) pp. 288-294. ISSN 1444-0903 (2016) [Refereed Article] DOI: 10.1111/imj.12964 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Van Tienen EC; Stafford A | |
| 2016 | Bezabhe WM, Chalmers L, Bereznicki LR, Gee P, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', Aids Care, 28, (8) pp. 1018-1022. ISSN 0954-0121 (2016) [Refereed Article] DOI: 10.1080/09540121.2016.1139039 [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Bezabhe WM; Chalmers L; Gee P; Peterson GM | |
| 2016 | Bezabhe WM, Chalmers L, Bereznicki LRE, Peterson GM, 'Adherence to antiretroviral therapy and virologic failure', Medicine, 95, (15) pp. 1-9. ISSN 0025-7974 (2016) [Refereed Article] DOI: 10.1097/MD.0000000000003361 [eCite] [Details] Citations: Scopus - 154Web of Science - 150 Co-authors: Bezabhe WM; Chalmers L; Peterson GM | |
| 2016 | Gheewala PA, Peterson GM, Zaidi STR, Bereznicki L, Jose MD, et al., 'A web-based training program to support chronic kidney disease screening by community pharmacists', International Journal of Clinical Pharmacy, 38, (5) pp. 1080-1086. ISSN 2210-7703 (2016) [Refereed Article] DOI: 10.1007/s11096-016-0330-5 [eCite] [Details] Citations: Scopus - 9Web of Science - 8 Co-authors: Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL | |
| 2016 | Obamiro KO, Chalmers L, Bereznicki LRE, 'A summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillation', American Journal of Cardiovascular Drugs, 16, (5) pp. 349-363. ISSN 1175-3277 (2016) [Refereed Article] DOI: 10.1007/s40256-016-0171-6 [eCite] [Details] Citations: Scopus - 43Web of Science - 40 Co-authors: Obamiro KO; Chalmers L | |
| 2016 | Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulation knowledge tool (AKT)', PloS one, 11, (6) Article e0158071. ISSN 1932-6203 (2016) [Refereed Article] DOI: 10.1371/journal.pone.0158071 [eCite] [Details] Citations: Scopus - 31Web of Science - 23 Co-authors: Obamiro KO; Chalmers L | |
| 2016 | Parameswaran Nair N, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, et al., 'Prediction of hospitalization due to adverse drug reactions in elderly community-dwelling patients (The PADR-EC Score)', PLoS One, 11, (10) pp. 1-17. ISSN 1932-6203 (2016) [Refereed Article] DOI: 10.1371/journal.pone.0165757 [eCite] [Details] Citations: Scopus - 43Web of Science - 38 Co-authors: Parameswaran Nair N; Chalmers L; Connolly M; Bereznicki BJ; Peterson GM; Curtain C; Castelino RL | |
| 2016 | Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, et al., 'Hospitalization in older patients due to adverse drug reactions - the need for a prediction tool', Clinical Interventions in Aging (Online), 11 pp. 497-505. ISSN 1178-1998 (2016) [Refereed Article] DOI: 10.2147/CIA.S99097 [eCite] [Details] Citations: Scopus - 90Web of Science - 87 Co-authors: Parameswaran Nair N; Chalmers L; Peterson GM; Bereznicki BJ; Castelino RL | |
| 2016 | Veal FC, Bereznicki LRE, Thompson AJ, Peterson GM, Orlikowski CE, 'Pain and functionality following sternotomy: a prospective 12-month observational study', Pain Medicine, 17, (6) pp. 1155-1162. ISSN 1526-2375 (2016) [Refereed Article] DOI: 10.1093/pm/pnv066 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Veal FC; Thompson AJ; Peterson GM | |
| 2016 | Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE, 'The effect of knowledge and expectations on adherence to and persistence with antidepressants', Patient Preference and Adherence, 10 pp. 761-768. ISSN 1177-889X (2016) [Refereed Article] DOI: 10.2147/PPA.S99803 [eCite] [Details] Citations: Scopus - 13Web of Science - 12 Co-authors: Woodward SC; Bereznicki BJ; Westbury JL | |
| 2015 | Bereznicki BJ, Beggs S, Duff C, Bereznicki L, 'Adherence to management guidelines for childhood asthma in Australia', Australian Family Physician, 44, (12) pp. 933-938. ISSN 0300-8495 (2015) [Refereed Article] PMID: 27054215 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Bereznicki BJ; Beggs S | |
| 2015 | Bernal DDL, Bereznicki LRE, Chalmers L, Castelino RL, Thompson A, et al., 'Medication adherence following acute coronary syndrome: does one size fit all?', American Journal of Cardiovascular Drugs, 16, (1) pp. 9-17. ISSN 1175-3277 (2015) [Refereed Article] DOI: 10.1007/s40256-015-0149-9 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Bernal DDL; Chalmers L; Castelino RL; Thompson A; Peterson GM | |
| 2015 | Bezabhe W, Bereznicki LRE, Chalmers L, Gee PR, Kassie DM, et al., 'Authors' Reply to Cotton and Nicol's Comment on Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia''', Drug Safety ISSN 0114-5916 (2015) [Letter or Note in Journal] DOI: 10.1007/s40264-015-0335-3 [eCite] [Details] Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM | |
| 2015 | Bezabhe WM, Bereznicki LR, Chalmers L, Gee P, Kassie DM, et al., 'Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia', Drug Safety, 38, (7) pp. 629-639. ISSN 0114-5916 (2015) [Refereed Article] DOI: 10.1007/s40264-015-0295-7 [eCite] [Details] Citations: Scopus - 17Web of Science - 13 Co-authors: Bezabhe WM; Chalmers L; Gee P; Peterson GM | |
| 2015 | Bindoff I, Cummings E, Ling T, Chalmers L, Bereznicki L, 'Development of a flexible and extensible computer-based simulation platform for healthcare students', Studies in Health Technology and Informatics, 208 pp. 83-87. ISSN 0926-9630 (2015) [Refereed Article] DOI: 10.3233/978-1-61499-488-6-83 [eCite] [Details] Co-authors: Bindoff I; Cummings E; Ling T; Chalmers L | |
| 2015 | Jose MD, Longmuir HD, Dodds B, Bereznicki L, Prasad R, et al., 'Anticoagulation for people receiving long-term haemodialysis', Cochrane Database of Systematic Reviews, (9) pp. 1-15. ISSN 1469-493X (2015) [Contribution to Refereed Journal] DOI: 10.1002/14651858.CD011858 [eCite] [Details] Citations: Scopus - 4Web of Science - 1 Co-authors: Jose MD; Longmuir HD; Dodds B | |
| 2015 | Schmid O, Chalmers L, Bereznicki L, 'Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease', Journal of Clinical Pharmacy and Therapeutics, 40, (4) pp. 398-403. ISSN 0269-4727 (2015) [Refereed Article] DOI: 10.1111/jcpt.12274 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Schmid O; Chalmers L | |
| 2015 | Veal FC, Bereznicki LRE, Thompson AJ, Peterson GM, 'Use of opioid analgesics in older Australians', Pain Medicine, 16, (8) pp. 1519-27. ISSN 1526-4637 (2015) [Refereed Article] DOI: 10.1111/pme.12720 [eCite] [Details] Citations: Scopus - 17Web of Science - 17 Co-authors: Veal FC; Thompson AJ; Peterson GM | |
| 2015 | Veal FC, Bereznicki LRE, Thompson AJ, Peterson GM, Orlikowski C, 'Subacute pain as a predictor of long-term pain following orthopedic surgery: an Australian prospective 12 month observational cohort study', Medicine, 94, (36) Article e1498. ISSN 0025-7974 (2015) [Refereed Article] DOI: 10.1097/MD.0000000000001498 [eCite] [Details] Citations: Scopus - 33Web of Science - 30 Co-authors: Veal FC; Thompson AJ; Peterson GM; Orlikowski C | |
| 2014 | Bereznicki L, 'Turning back time with botulinum toxin', Australian Pharmacist, 33, (7) pp. 62-65. ISSN 0728-4632 (2014) [Professional, Refereed Article] | |
| 2014 | Bereznicki L, 'Heart Failure', Australian Pharmacist, 33, (10) pp. 56-59. ISSN 0728-4632 (2014) [Professional, Refereed Article] | |
| 2014 | Bereznicki L, 'Novel oral anticoagulants in atrial fibrillation', Australian Pharmacist, 33, (10) pp. 62-66. ISSN 0728-4632 (2014) [Professional, Refereed Article] | |
| 2014 | Bereznicki LRE, 'Infective Conjunctivitis', Australian Pharmacist, 33, (10) pp. 62-66. ISSN 0728-4632 (2014) [Professional, Refereed Article] | |
| 2014 | Bereznicki LRE, 'Targeting medication review services', Australian Pharmacist pp. 24. ISSN 0728-4632 (2014) [Contribution to Refereed Journal] | |
| 2014 | Bereznicki LRE, 'Anticoagulation in atrial fibrillation', Australian Pharmacist ISSN 0728-4632 (2014) [Professional, Refereed Article] | |
| 2014 | Bereznicki LRE, Jackson SL, Kromdijk W, Gee P, Fitzmaurice K, et al., 'Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study', International Journal of Pharmacy Practice, 22, (1) pp. 84-91. ISSN 0961-7671 (2014) [Refereed Article] DOI: 10.1111/ijpp.12035 [eCite] [Details] Citations: Scopus - 5 Co-authors: Jackson SL; Gee P; Fitzmaurice K; Bereznicki BJ; Peterson GM | |
| 2014 | Bernal D, Bereznicki LRE, Peterson GM, 'With great power comes great responsibility', Medical Journal of Australia, 200, (6) pp. 321. ISSN 0025-729X (2014) [Letter or Note in Journal] DOI: 10.5694/mja13.00061 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Bernal D; Peterson GM | |
| 2014 | Bernal D, Bereznicki LRE, Peterson GM, 'Improving Medication Adherence and Helping Patients Make Lifestyle Changes', JAMA Internal Medicine, 174, (10) pp. 1707-8. ISSN 2168-6106 (2014) [Letter or Note in Journal] DOI: 10.1001/jamainternmed.2014.669 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Bernal D; Peterson GM | |
| 2014 | Bernal D, Chalmers L, Bereznicki LRE, Castelino RL, Davidson PM, et al., 'An online person-centered education package for pharmacists delivering a home medication review service to patients following acute coronary syndromes', European Journal for Person Centered Healthcare, 2, (3) pp. 408-415. ISSN 2052-5656 (2014) [Refereed Article] Co-authors: Bernal D; Chalmers L; Castelino RL; Davidson PM; Peterson GM | |
| 2014 | Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, et al., 'Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia', PLoS One, 9, (5) Article e97353. ISSN 1932-6203 (2014) [Refereed Article] DOI: 10.1371/journal.pone.0097353 [eCite] [Details] Citations: Scopus - 123Web of Science - 109 Co-authors: Bezabhe WM; Chalmers L; Peterson GM | |
| 2014 | Bindoff I, Ling T, Bereznicki L, Westbury J, Chalmers L, et al., 'A computer simulation of community pharmacy practice for educational use', American Journal of Pharmaceutical Education, 78, (9) Article 168. ISSN 0002-9459 (2014) [Refereed Article] DOI: 10.5688/ajpe789168 [eCite] [Details] Citations: Web of Science - 31 Co-authors: Bindoff I; Ling T; Westbury J; Chalmers L; Peterson G; Ollington R | |
| 2014 | Bista D, Chalmers L, Bereznicki L, Peterson G, 'Potential use of NOACs in developing countries: pros and cons', European Journal of Clinical Pharmacology, 70, (7) pp. 817-828. ISSN 1432-1041 (2014) [Refereed Article] DOI: 10.1007/s00228-014-1693-y [eCite] [Details] Citations: Scopus - 12Web of Science - 13 Co-authors: Bista D; Chalmers L; Peterson G | |
| 2014 | Stewart K, George J, McNamara KP, Jackson SL, Peterson GM, et al., 'A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)', Journal of Clinical Pharmacy and Therapeutics, 39, (5) pp. 527-534. ISSN 0269-4727 (2014) [Refereed Article] DOI: 10.1111/jcpt.12185 [eCite] [Details] Citations: Scopus - 67Web of Science - 60 Co-authors: Peterson GM; Gee PR | |
| 2014 | Veal FC, Bereznicki LR, Thompson AJ, Peterson GM, 'Pharmacological management of pain in Australian Aged Care Facilities', Age and Ageing, 43, (6) pp. 851-856. ISSN 1468-2834 (2014) [Refereed Article] DOI: 10.1093/ageing/afu072 [eCite] [Details] Citations: Scopus - 20Web of Science - 19 Co-authors: Veal FC; Thompson AJ; Peterson GM | |
| 2013 | Bereznicki BJ, Norton LC, Beggs SA, Gee P, Bereznicki LRE, 'Review of the management of childhood asthma in Tasmania', Journal of Paediatrics and Child Health, 49, (8) pp. 678-683. ISSN 1034-4810 (2013) [Refereed Article] DOI: 10.1111/jpc.12267 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Bereznicki BJ; Beggs SA; Gee P | |
| 2013 | Bereznicki L, 'Stroke prevention in atrial fibrillation: Novel anticoagulants', Australian Pharmacist, 32, (4) pp. 64-69. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] | |
| 2013 | Bereznicki L, 'The role of newer antidepressants in treating major depression', Australian Pharmacist, 10, (32) pp. 60-65. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] | |
| 2013 | Bereznicki L, Bereznicki B, 'Beta-blockers in asthma', Australian Pharmacist, 32, (5) pp. 54-57. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] Co-authors: Bereznicki B | |
| 2013 | Bereznicki L, Castelino R, 'Understanding randomised controlled trials', Australian Pharmacist, 32, (4) pp. 71-72. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] Co-authors: Castelino R | |
| 2013 | Bereznicki LRE, 'Melanoma', Australian Pharmacist, 32, (2) pp. 58-62. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] | |
| 2013 | Bereznicki LRE, Castelino RL, 'Understanding Systematic Reviews', Australian Pharmacist, (August) pp. 68-69. ISSN 0728-4632 (2013) [Professional, Non Refereed Article] Co-authors: Castelino RL | |
| 2013 | Bereznicki LRE, Jackson SL, Peterson GM, 'Supervised patient self-testing of Warfarin therapy using an online system', Journal of Medical Internet Research, 15, (7) Article e138. ISSN 1439-4456 (2013) [Refereed Article] DOI: 10.2196/jmir.2255 [eCite] [Details] Citations: Scopus - 16Web of Science - 13 Co-authors: Jackson SL; Peterson GM | |
| 2013 | Bereznicki LRE, Madden A, Peterson GM, 'The quality of international normalised ratio control in southern Tasmania', Medical Journal of Australia, 198, (6) pp. 315. ISSN 0025-729X (2013) [Refereed Article] DOI: 10.5694/mja12.11370 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Madden A; Peterson GM | |
| 2013 | Bezabhe WM, Peterson GM, Bereznicki L, Chalmers L, Gee P, 'Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol', BMJ Open, 3, (10) Article e003559. ISSN 2044-6055 (2013) [Contribution to Refereed Journal] DOI: 10.1136/bmjopen-2013-003559 [eCite] [Details] Citations: Scopus - 6Web of Science - 8 Co-authors: Bezabhe WM; Peterson GM; Chalmers L; Gee P | |
| 2013 | Castelino R, Bereznicki L, 'Understanding non-randomised study designs', Australian Pharmacist, 32, (6) pp. 63-64. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] Co-authors: Castelino R | |
| 2013 | Castelino RL, Bereznicki LRE, 'The basics of evidence-based medicine', Australian Pharmacist, 32, (2) pp. 72-74. ISSN 0728-4632 (2013) [Refereed Article] Co-authors: Castelino RL | |
| 2013 | Castelino RL, Bereznicki LRE, 'How to read and interpret clinical trials', Australian Pharmacist, 32, (10) pp. 68-69. ISSN 0728-4632 (2013) [Non Refereed Article] Co-authors: Castelino RL | |
| 2013 | Mirkazemi C, Bereznicki LR, Peterson GM, 'Thromboprophylaxis following hip and knee arthroplasty', Internal Medicine Journal, 43, (2) pp. 124-129. ISSN 1444-0903 (2013) [Refereed Article] DOI: 10.1111/j.1445-5994.2013.02864.x [eCite] [Details] Citations: Scopus - 7Web of Science - 5 Co-authors: Mirkazemi C; Peterson GM | |
| 2013 | Mirkazemi C, Bereznicki LRE, Peterson GM, 'Response to Re: Are the national orthopaedic thromboprophylaxis guidelines appropriate?', ANZ Journal of Surgery, 83, (5) pp. 395-396. ISSN 1445-1433 (2013) [Letter or Note in Journal] DOI: 10.1111/ans.12119 [eCite] [Details] Co-authors: Mirkazemi C; Peterson GM | |
| 2012 | Bereznicki L, 'Head Lice', Australian Pharmacist, 31, (2) pp. 142-146. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bereznicki L, 'Antibiotics for acute otitis media in children', Australian Pharmacist, 31, (4) pp. 308-310. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bereznicki L, 'Factors affecting wound healing', Australian Pharmacist, 31, (6) pp. 484-487. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bereznicki L, 'Post traumatic stress disorder', Australian Pharmacist, (September 2012) pp. 738 - 741. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bereznicki L, 'Eating Disorders', Australian Pharmacist, (December 2012) pp. 968-972. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bereznicki LRE, 'Changes to HMR business rules', Australian Pharmacist, 31, (3) pp. 186. ISSN 0728-4632 (2012) [Professional, Non Refereed Article] | |
| 2012 | Bereznicki LRE, 'Managing glycaemia in type 2 diabetes', Australian Pharmacist, (July) pp. 566 - 570. ISSN 0728-4632 (2012) [Professional, Refereed Article] | |
| 2012 | Bernal DDL, Stafford L, Bereznicki LRE, Castelino RL, Davidson PM, et al., 'Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial', Trials, 13, (30) pp. 1-17. ISSN 1745-6215 (2012) [Refereed Article] DOI: 10.1186/1745-6215-13-30 [eCite] [Details] Citations: Scopus - 7Web of Science - 4 Co-authors: Bernal DDL; Stafford L; Castelino RL; Peterson GM | |
| 2012 | Mirkazemi C, Bereznicki LR, Peterson GM, 'Are the national orthopaedic thromboprophylaxis guidelines appropriate?', ANZ Journal of Surgery, 82, (12) pp. 913-917. ISSN 1445-1433 (2012) [Refereed Article] DOI: 10.1111/j.1445-2197.2012.06203.x [eCite] [Details] Citations: Scopus - 10Web of Science - 10 Co-authors: Mirkazemi C; Peterson GM | |
| 2012 | Peterson GM, Stafford L, Van Tienen E, Bereznicki L, 'Anticoagulant therapy in the elderly: the importance of health literacy', Australian Pharmacist, 31, (1) pp. 32-34. ISSN 0728-4632 (2012) [Refereed Article] Co-authors: Peterson GM; Stafford L; Van Tienen E | |
| 2012 | Stafford L, Van Tienen EC, Bereznicki LRE, Peterson GM, 'The benefits of pharmacist-delivered warfarin education in the home', International Journal of Pharmacy Practice, 20, (6) pp. 384-389. ISSN 0961-7671 (2012) [Refereed Article] DOI: 10.1111/j.2042-7174.2012.00217.x [eCite] [Details] Citations: Scopus - 13 Co-authors: Stafford L; Van Tienen EC; Peterson GM | |
| 2012 | Stafford L, Van Tienen EC, Peterson GM, Bereznicki LRE, Jackson SL, et al., 'Warfarin management after discharge from hospital: a qualitative analysis', Journal of Clinical Pharmacy and Therapeutics, 37, (4) pp. 410-414. ISSN 0269-4727 (2012) [Refereed Article] DOI: 10.1111/j.1365-2710.2011.01308.x [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Stafford L; Van Tienen EC; Peterson GM; Jackson SL | |
| 2011 | Bereznicki LRE, 'Primary open-angle glaucoma', Australian Pharmacist, 30, (2) pp. 140-146. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] | |
| 2011 | Bereznicki LRE, 'Urinary incontinence', Australian Pharmacist, 30, (4) pp. 318-322. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] | |
| 2011 | Bereznicki LRE, 'Fungal foot infections', Australian Pharmacist, 30, (8) pp. 670-674. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] | |
| 2011 | Bereznicki LRE, 'Rheumatoid Arthritis', Australian Pharmacist, 30, (10) pp. 858-863. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] | |
| 2011 | Bereznicki LRE, 'Xerostomia', Australian Pharmacist, 30, (12) pp. 1022-1025. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] | |
| 2011 | Bereznicki LRE, Thompson AJ, 'Medicine-induced pulmonary toxicity', Australian Pharmacist, 30, (6) pp. 494-498. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] Co-authors: Thompson AJ | |
| 2011 | Singh P, Arrevad PS, Peterson GM, Bereznicki LR, 'Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities', Journal of Clinical Pharmacy and Therapeutics, 36, (2) pp. 166-171. ISSN 0269-4727 (2011) [Refereed Article] DOI: 10.1111/j.1365-2710.2010.01167.x [eCite] [Details] Citations: Scopus - 20Web of Science - 16 Co-authors: Peterson GM | |
| 2011 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study', BMC Health Services Research, 11, (16) pp. 1-11. ISSN 1472-6963 (2011) [Contribution to Refereed Journal] DOI: 10.1186/1472-6963-11-16 [eCite] [Details] Citations: Scopus - 11Web of Science - 8 Co-authors: Stafford L; Peterson GM; Jackson SL | |
| 2011 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Van Tienen EC, et al., 'Clinical Outcomes of a Collaborative, Home-Based Postdischarge Warfarin Management Service', The Annals of Pharmacotherapy, 45, (3) pp. 325-334. ISSN 1060-0280 (2011) [Refereed Article] DOI: 10.1345/aph.1P617 [eCite] [Details] Citations: Scopus - 35Web of Science - 31 Co-authors: Stafford L; Peterson GM; Jackson SL; Van Tienen EC | |
| 2011 | Stafford L, Stafford A, Hughes J, Angley M, Bereznicki L, et al., 'Drug-related problems identified in post-discharge medication reviews for patients taking warfarin', International Journal of Clinical Pharmacy, 33, (4) pp. 621-626. ISSN 2210-7703 (2011) [Refereed Article] DOI: 10.1007/s11096-011-9515-0 [eCite] [Details] Citations: Scopus - 21Web of Science - 17 Co-authors: Stafford L; Stafford A; Hughes J; Peterson G | |
| 2011 | Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, et al., 'Drug-Related Problems Detected in Australian Community Pharmacies: The PROMISe Trial', The Annals of Pharmacotherapy, 45, (9) pp. 1067-1076. ISSN 1542-6270 (2011) [Refereed Article] DOI: 10.1345/aph.1Q138 [eCite] [Details] Citations: Scopus - 28Web of Science - 24 Co-authors: Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Jackson SL | |
| 2010 | Bereznicki L, 'Managing attention deficit hyperactivity disorder in children', Australian Pharmacist, 29, (4 ) pp. 331-335. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] | |
| 2010 | Bereznicki L, 'Incretin-based therapies', Australian Pharmacist, 29, (6) pp. 508-513. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] | |
| 2010 | Bereznicki L, 'Management of hypertension', Australian Pharmacist, 29, (10) pp. 872-878. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] | |
| 2010 | Bereznicki L, 'Hormone replacement therapy for menopause', Australian Pharmacist, 29, (2) pp. 148-152. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] | |
| 2010 | Bereznicki L, 'Dopamine agonists in Parkinson's disease', Australian Pharmacist, 29, (12) pp. 1056-1062. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] | |
| 2010 | Bereznicki L, Bereznicki BJ, 'Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events', Australian Pharmacist, 29, (8) pp. 690-694. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] Co-authors: Bereznicki BJ | |
| 2010 | Bereznicki LRE, Peterson GM, 'New antithrombotics for Atrial Fibrillation', Cardiovascular Therapeutics, 28, (5) pp. 278-286. ISSN 1755-5914 (2010) [Refereed Article] DOI: 10.1111/j.1755-5922.2010.00209.x [eCite] [Details] Citations: Scopus - 19Web of Science - 17 Co-authors: Peterson GM | |
| 2010 | Luinstra M, Naunton M, Peterson GM, Bereznicki L, 'PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation', Journal of Clinical Pharmacy and Therapeutics, 35, (2) pp. 213-217. ISSN 0269-4727 (2010) [Refereed Article] DOI: 10.1111/j.1365-2710.2009.01089.x [eCite] [Details] Citations: Scopus - 15Web of Science - 13 Co-authors: Peterson GM | |
| 2010 | Peterson GM, Bereznicki L, 'Therapeutic catch 22 - Warfarin use in the elderly', Australian Pharmacist, 29, (3) pp. 246-250. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2010 | Peterson GM, Stafford L, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Point-of-care testing', Australian Prescriber, 33, (6) pp. 167-168. ISSN 0312-8008 (2010) [Letter or Note in Journal] Co-authors: Peterson GM; Stafford L; Van Tienen EC; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Van Tienen EC, 'Training Australian pharmacists for participation in a collaborative, home-based post-discharge warfarin management service', Pharmacy World & Science, 32, (5) pp. 637-642. ISSN 0928-1231 (2010) [Refereed Article] DOI: 10.1007/s11096-010-9416-7 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Co-authors: Stafford L; Peterson GM; Jackson SL; Van Tienen EC | |
| 2010 | Stafford L, Van Tienen EC, Bereznicki L, Peterson GM, 'Anticoagulation monitoring services', Australian Pharmacist, 29, (3) pp. 221-225. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] Co-authors: Stafford L; Van Tienen EC; Peterson GM | |
| 2009 | Bereznicki BJ, Bereznicki LRE, 'When asthma and COPD overlap each other', Australian Pharmacist, 28, (9) pp. 782-786. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Bereznicki BJ | |
| 2009 | Bereznicki LRE, 'Non-melanoma skin cancer', Australian Pharmacist, 28, (3) pp. 240-245. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] | |
| 2009 | Bereznicki LRE, 'Glycaemic control in type 2 diabetes: what is the target?', Australian Pharmacist, 28, (7) pp. 596-601. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] | |
| 2009 | Bereznicki LRE, 'Antioxidants and the prevention of cancer', Australian Pharmacist, 28, (8) pp. 686-691. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] | |
| 2009 | Bereznicki LRE, 'Clopidogrel and PPIs: what is the current evidence?', Australian Pharmacist, 28, (11) pp. 943. ISSN 0728-4632 (2009) [Letter or Note in Journal] | |
| 2009 | Bereznicki LRE, 'Calcium and vitamin D in osteoporosis', Australian Pharmacist, 28, (12) pp. 1064-1070. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] | |
| 2009 | Bereznicki LRE, Peterson GM, 'Medications used in assisted reproduction', Australian Pharmacist, 28 , (1) pp. 60-62. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2009 | Bereznicki LRE, Peterson GM, 'Multimorbidity and the elderly', Australian Pharmacist, 28, (11) pp. 978-983. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2009 | Bereznicki LRE, Stafford L, Jeffrey EC, Peterson GM, Jackson SL, 'Who is responsible for the care of patients treated with warfarin therapy?', The Medical Journal of Australia, 191, (10) pp. 575-576. ISSN 0025-729X (2009) [Letter or Note in Journal] DOI: 10.5694/j.1326-5377.2009.tb03321.x [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Stafford L; Jeffrey EC; Peterson GM; Jackson SL | |
| 2009 | Jeffrey EC, Bereznicki LRE, 'Infant formulas', Australian Pharmacist, 28, (2) pp. 140-144. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Jeffrey EC | |
| 2009 | Jeffrey EC, Bereznicki LRE, 'Inflammatory bowel disease', Australian Pharmacist, 28, (6) pp. 504-509. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Jeffrey EC | |
| 2009 | Luinstra M, Naunton M, Peterson GM, Bereznicki LRE, 'Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients', Journal of Pharmacy Practice and Research , 39, (4) pp. 265-268. ISSN 1445-937X (2009) [Refereed Article] DOI: 10.1002/j.2055-2335.2009.tb00471.x [eCite] [Details] Co-authors: Luinstra M; Peterson GM | |
| 2009 | Stafford AC, Bereznicki LRE, 'Prevention and treatment of drug-resistant Staphylococcus aureus', Australian Pharmacist, 28, (4) pp. 332-337. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Stafford AC | |
| 2009 | Stafford L, Bereznicki LRE, 'Statins as primary prevention in patients without dislipidaemia', Australian Pharmacist, 28, (5) pp. 422-426. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Stafford L | |
| 2009 | Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'PROMISe to document clinical interventions in Australian community pharmacies', Australian Pharmacist, 28, (2) pp. 162-164. ISSN 0728-4632 (2009) [Refereed Article] Co-authors: Williams Mackenzie; Peterson GM; Tenni PC | |
| 2008 | Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage asthma', Australian Pharmacist, 27, (5) pp. 414-418. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Bereznicki BJ; Peterson GM | |
| 2008 | Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage COPD', Australian Pharmacist, 27, (6) pp. 485-491. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Bereznicki BJ; Peterson GM | |
| 2008 | Bereznicki LRE, 'Very-low calorie diets: a review of the evidence', Australian Pharmacist, 27, (9) pp. 724-727. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] | |
| 2008 | Bereznicki LRE, Peterson GM, 'New medications to treat type 2 diabetes', Australian Pharmacist, 27, (3) pp. 246-251. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'Adverse drug events and the role of the pharmacy', Australian Pharmacist, 27, (9) pp. 750-756. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'External ear problems', Australian Pharmacist, 27, (10) pp. 838-847. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'Statins in the elderly', Australian Pharmacist, 27, (7) pp. 579-584. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'Weight management', Australian Pharmacist, 27, (8) pp. 658-663. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'Vitamin supplements in the elderly', Australian Pharmacist, 27, (12) pp. 1010-1014. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki LRE, Peterson GM, 'Bisphosphonates and osteomyelitis of the jaw', Australian Pharmacist, 27, (11) pp. 927-931. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2008 | Jackson SL, Bereznicki LRE, Peterson GM, Jeffrey EC, 'An update on INR monitoring', Australian Pharmacist, 27, (7) pp. 562-564. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM; Jeffrey EC | |
| 2008 | Nash RE, Bereznicki LRE, Peterson GM, 'Smoking cessation', AusPharm Continuing Education pp. 1-8. (2008) [Professional, Non Refereed Article] Co-authors: Nash RE; Peterson GM | |
| 2008 | Peterson GM, Bereznicki LRE, 'Recent issues with paracetamol: don't throw the baby out with the bathwater', Australian Pharmacist, 27, (11) pp. 900-901. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2007 | Bereznicki B, Bereznicki L, Jackson S, Peterson G, 'How can pharmacists improve asthma control in the community?', Australian Pharmacist, 26, (7) pp. 566-567. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Bereznicki B; Jackson S; Peterson G | |
| 2007 | Bereznicki LRE, Jackson SL, Morgan SO, Boland C, Marsden KA, et al., 'Improving clinical outcomes for hospital patients initiated on warfarin', Journal of Pharmacy Practice and Research, 37, (4) pp. 295-302. ISSN 1445-937X (2007) [Refereed Article] DOI: 10.1002/j.2055-2335.2007.tb00769.x [eCite] [Details] Citations: Scopus - 4 Co-authors: Jackson SL; Marsden KA; Jupe DML; Vial JH; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, 'Substituting phenylephrine for pseudoephedrine as a nasal decongestant: is it evidence-based?', Australian Pharmacist, 26, (4) pp. 298-299. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, 'Encouraging the rational use of probiotics in combination with antibiotics - what are we trying to prevent?', Australian Pharmacist, 26, (1) pp. 26. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, 'Improving aspirin use among adults with diabetes', Australian Pharmacist, 26, (6) pp. 458459. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, 'Coenzyme Q10 and statin-associated myopathy', Australian Pharmacist, 26, (10) pp. 794. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, Jeffrey EC, Marsden KA, et al., 'Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring', Journal of Clinical Pathology, 60, (60) pp. 311-314. ISSN 0021-9746 (2007) [Refereed Article] DOI: 10.1136/jcp.2006.037820 [eCite] [Details] Citations: Scopus - 69Web of Science - 59 Co-authors: Jackson SL; Peterson GM; Jeffrey EC; Marsden KA; Jupe DML | |
| 2007 | Bereznicki LRE, Peterson GM, 'Warfarin management in Australia: what can pharmacists offer?', Australian Pharmacist, 26, (12) pp. 954-955. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2006 | Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC, 'The risks of warfarin use in the elderly', Expert Opinion on Drug Safety, 5, (3) pp. 417-431. ISSN 1474-0338 (2006) [Refereed Article] DOI: 10.1517/14740338.5.3.417 [eCite] [Details] Citations: Scopus - 15Web of Science - 12 Co-authors: Peterson GM; Jackson SL; Jeffrey EC | |
| 2006 | Bereznicki LRE, Jackson SL, 'Comment: Increased sensitivity to warfarin after heart valve replacement', The Annals of Pharmacotherapy, 40, (7) pp. 1476-1477. ISSN 1060-0280 (2006) [Letter or Note in Journal] DOI: 10.1345/aph.1G407a [eCite] [Details] Co-authors: Jackson SL | |
| 2006 | Bereznicki LRE, Jackson SL, Jeffrey EC, Peterson GM, 'Home-monitoring of warfarin (the ultimate strategy to improve the safety of anticoagulation)', Australian Pharmacist, 25, (3) pp. 246-251. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Jeffrey EC; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Combining aspirin and clopidogrel: when is one better than both?', Australian Pharmacist, 25, (6) pp. 480. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Preventing age-related macular degeneration', Australian Pharmacist, 25, (3) pp. 244. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation', Journal of Pharmacy Practice and Research, 36, (2) pp. 162. ISSN 1445-937X (2006) [Letter or Note in Journal] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Which is the safest NSAID for patients at elevated cardiovascular risk?', Australian Pharmacist, 25, (11) pp. 853. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Encouraging periconceptional use of folic acid supplements', Australian Pharmacist, 25, (9) pp. 706. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, 'Preventing age-related macular degeneration', Australian Pharmacist, 25, (3) pp. 244-245. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Jackson SL, Bereznicki LRE, Peterson GM, 'Preventing osteoporosis-related fractures', Australian Pharmacist, 25, (4) pp. 318. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Jackson SL, Bereznicki LRE, Peterson GM, 'Hypertension', Australian Pharmacist, 25, (2) pp. 158. ISSN 0728-4632 (2006) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2006 | Peterson GM, Bereznicki LRE, 'Multivitamins and breast cancer risk - no need to panic', Australian Pharmacist, 29, (6) pp. 444. ISSN 0728-4632 (2006) [Letter or Note in Journal] Co-authors: Peterson GM | |
| 2006 | Peterson GM, Jackson SL, Bereznicki LRE, 'Evidence-practice gaps', Australian Pharmacist, 25, (1) pp. 6. ISSN 0728-4632 (2006) [Letter or Note in Journal] Co-authors: Peterson GM; Jackson SL | |
| 2005 | Bereznicki LRE, Jackson SL, Peterson GM, 'The direct thrombin inhibitor melagatran/ximelagatran', Medical Journal of Australia, 182, (5) pp. 254-255. ISSN 0025-729X (2005) [Letter or Note in Journal] DOI: 10.5694/j.1326-5377.2005.tb06686.x [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Jackson SL; Peterson GM | |
| 2005 | Bereznicki LRE, Jackson SL, Peterson GM, 'Closing the gap between evidence and practice', Journal of Pharmacy Practice and Research, 35, (3) pp. 173-176. ISSN 1445-937X (2005) [Letter or Note in Journal] DOI: 10.1002/j.2055-2335.2005.tb00330.x [eCite] [Details] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Bereznicki LRE, Peterson GM, Jackson SL, 'Venous thromboembolism: under-use of prophylaxis for medical and nursing home patients', Australian Pharmacist, 24, (5) pp. 402-404. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Peterson GM; Jackson SL | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, 'An important role for community pharmacy in reducing evidence gaps', Australian Pharmacist, 24, (7) pp. 558. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, 'Under-use of B-Blockers', Australian Pharmacist, 24, (9) pp. 691. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, 'Hypertension', Australian Pharmacist, 25, (2) pp. 158139. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, 'Under-use of ACE-inhibitor and B-Blocker therapies in congestive cardiac failure', Australian Pharmacist, 24, (12) pp. 936. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, 'Over-use of antibiotics for acute otitis media', Australian Pharmacist, 24, (10) pp. 200. ISSN 0728-4632 (2005) [Letter or Note in Journal] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Peterson GM, Bereznicki LRE, 'Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR', American Heart Journal, 149, (1) pp. E1. ISSN 0002-8703 (2005) [Letter or Note in Journal] Co-authors: Jackson SL; Peterson GM | |
| 2005 | Jackson SL, Peterson GM, Bereznicki LRE, Misan GM, Jupe DML, et al., 'Improving the outcomes of anticoagulation in rural Australia: An evaluation of pharmacist-assisted monitoring of warfarin therapy', Journal of Clinical Pharmacy and Therapeutics, 30, (4) pp. 345-353. ISSN 0269-4727 (2005) [Refereed Article] DOI: 10.1111/j.1365-2710.2005.00656.x [eCite] [Details] Citations: Scopus - 34Web of Science - 27 Co-authors: Jackson SL; Peterson GM; Jupe DML; Vial JH | |
| 2005 | Naunton M, Peterson GM, Bereznicki LRE, Jackson SL, 'The enigma of aspirin in primary prevention', Australian Pharmacist, 24, (9) pp. 718-722. ISSN 0728-4632 (2005) [Professional, Non Refereed Article] Co-authors: Peterson GM; Jackson SL | |
| 2005 | Peterson GM, Bereznicki LRE, 'Protection of the public or protection of the pharmaceutical industry?', Australian Prescriber, 28, (4) pp. 86. ISSN 0312-8008 (2005) [Letter or Note in Journal] Co-authors: Peterson GM | |
| 2005 | Peterson GM, Jackson SL, Bereznicki LRE, 'Evidence-practice gaps', Australian Pharmacist, 25, (1) pp. 6. ISSN 0728-4632 (2005) [Letter or Note in Journal] Co-authors: Peterson GM; Jackson SL | |
| 2004 | Jackson SL, Bereznicki LRE, Peterson GM, Marsden KA, Jupe DML, et al., 'Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice', Australian Journal of Rural Health, 12, (4) pp. 137-142. ISSN 1038-5282 (2004) [Refereed Article] DOI: 10.1111/j.1440-1854.2004.00585.x [eCite] [Details] Citations: Scopus - 27 Co-authors: Jackson SL; Peterson GM; Marsden KA; Vial JH | |
| 2004 | Jackson SL, Bereznicki LRE, Peterson GM, Marsden KA, Jupe DML, et al., 'Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic', Clinical and Laboratory Haematology, 26, (1) pp. 49-55. ISSN 0141-9854 (2004) [Refereed Article] DOI: 10.1111/j.0141-9854.2003.00578.x [eCite] [Details] Citations: Scopus - 29Web of Science - 25 Co-authors: Jackson SL; Peterson GM; Marsden KA; Tegg EM; Vial JH; Kimber R | |
| 2002 | Peterson GM, Jackson SL, Bereznicki LRE, 'Stroke prevention - anticoagulation for atrial fibrillation', Australian Pharmacist, 21, (3) pp. 203-206. ISSN 0728-4632 (2002) [Refereed Article] Co-authors: Peterson GM; Jackson SL |
Book
(3 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2015 | Bereznicki LRE, 'Antithrombotics Essential CPE', Pharmaceutical Society of Australia Ltd., Australia, pp. 50. (2015) [Revision/New Edition] | |
| 2013 | Bereznicki LRE, Thompson M, Sussman G, Greig L, 'Wound Care in Practice', Pharmaceutical Society of Australia Ltd, Australia, pp. 80. (2013) [Authored Other Book] | |
| 2009 | Bereznicki LRE, 'Anti-thrombotics Essential CPE- Continuing education from the Pharmaceutical Society of Australia', Pharmaceutical Society of Australia, ACT, pp. 1-72. ISBN 978-0-9807235-0-2 (2009) [Authored Other Book] |
Chapter in Book
(1 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2011 | Bereznicki LRE, 'Dabigatran (Pradaxa) for atrial fibrillation', Annual Medicines Update 2011, Pharmaceutical Society of Australia, Marnie Firipis (ed), Deakin ACT, Australia, pp. 20-24. ISBN 978-0-9807235-6-4 (2011) [Other Book Chapter] |
Conference Publication
(124 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2022 | Atey T, Peterson G, Salahudeen M, Bereznicki L, Wimmer B, et al., 'Comparing the intervention of partnered pharmacist medication charting to early/late possible medication history', The 46th SHPA National Conference, 1 - 3 December 2022, Brisbane, Australia (2022) [Conference Extract] Co-authors: Atey T; Peterson G; Salahudeen M; Wimmer B; Simpson T; Boland C | |
| 2022 | Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer BC, 'Impact of partnered pharmacist medication charting on potentially inappropriate medication use', APSA-ASCEPT 2022, 29 November - 02 December 2022, Perth, Australia (2022) [Conference Extract] Co-authors: Atey TM; Peterson GM; Salahudeen MS; Wimmer BC | |
| 2022 | Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer BC, 'Impact of partnered pharmacist medication charting on potentially inappropriate medication use', APSA-ASCEPT 2022, 29 November - 02 December 2022, Perth, Australia (2022) [Conference Extract] Co-authors: Atey TM; Peterson GM; Salahudeen MS; Wimmer BC | |
| 2021 | Ali S, Salahudeen MS, Bereznicki LRE, Curtain CM, 'Pharmacist's interventions to reduce the occurrence of drug-related harms in older residents: a systematic review', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, virtual, pp. 29. (2021) [Conference Extract] Co-authors: Ali S; Salahudeen MS; Curtain CM | |
| 2021 | Atey T, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer B, 'Impact of partnered pharmacist medication charting in the Royal Hobart Hospital emergency department on medication discrepancies and errors: preliminary results', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, virtual, pp. 36. (2021) [Conference Extract] Co-authors: Atey T; Peterson GM; Salahudeen MS; Wimmer B | |
| 2021 | Cousins J, Parameswaran Nair N, Curtain CM, Bereznicki BJ, Wilson KM, et al., 'Preventing adverse drug reactions after discharge: protocol for a randomised controlled trial in older people', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, online, pp. 251. (2021) [Conference Extract] Co-authors: Cousins J; Parameswaran Nair N; Curtain CM; Bereznicki BJ; Wilson KM | |
| 2021 | Schmid O, Bereznicki B, Peterson G, Stankovich J, Bereznicki LRE, 'The burden of hospital admissions for adverse drug reactions in Tasmania', NPS MedicineWise, 18 May 2021, Online (2021) [Conference Extract] Co-authors: Schmid O; Bereznicki B; Peterson G; Stankovich J | |
| 2021 | Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Adverse drug reaction-related hospitalisations among people with dementia', APSA-ASCEPT 2022 Joint Conference Book of Abstracts, 29 November - 02 December 2022, Perth, pp. 312. (2021) [Conference Extract] Co-authors: Zaidi AS; Peterson GM; Curtain CM; Salahudeen MS | |
| 2019 | Ali S, Peterson GM, Bereznicki LRE, Salahudeen MS, 'Association between anticholinergic drug burden and mortality in older people: an evidence-based approach', 22-26 September 2019, Abu Dhabi, United Arab Emirates (2019) [Conference Edited] Co-authors: Peterson GM; Salahudeen MS | |
| 2018 | Thompson A, Bereznicki LR, Chalmers L, Anderson T, 'Promoting antimicrobial stewardship in the community - are nurses an untapped resource?', NPS MedicineWise Conference, National Medicine Symposium (NMS), 30 May - 1 June 2018, Canberra, Australia (2018) [Conference Extract] Co-authors: Thompson A; Chalmers L | |
| 2017 | Alamneh EA, Chalmers L, Bereznicki L, 'Oral anticoagulant use in patients with atrial fibrillation: pre- vs. post-direct oral anticoagulant era comparisons', ESC Congress 2017, 26-30 August 2017, Barcelona (2017) [Conference Extract] Co-authors: Chalmers L | |
| 2017 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Gaps in anticoagulation knowledge in patients with atrial fibrillation', ASCEPT ASM / 2017 Annual Scientific Meeting, 5-8 December 2017, Brisbane, Australia (2017) [Conference Extract] Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki BJ | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki B, Curtain C, Connolly M, et al., 'Readmissions to hospital due to adverse drug reactions in elderly Australians', ISPOR 22nd Annual International Conference, 20-24 May 2017, Boston (2017) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki B; Curtain C; Connolly M | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki B, Curtain CM, Connolly M, et al., 'Repeat Adverse Drug Reactions-related Hospital Admissions in Elderly Australians', International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting, 20-24 May 2017, Boston (2017) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki B; Curtain CM | |
| 2016 | Admassie E, Chalmers L, Bereznicki LRE, 'The Tasmanian Atrial Fibrillation Study: Transition to Direct Oral Anticoagulants, 2011-2015', APSA Annual Conference 2016, 2-5 December, 2016, Sydney, Australia (2016) [Conference Extract] Co-authors: Admassie E; Chalmers L | |
| 2016 | Bereznicki BJ, Walters EH, Walters JAE, Peterson GM, Bereznicki LRE, 'Under-utilisation of COPD management guidelines in Australian general practice', Respirology, 2-6 April, 2016, Perth, Australia, pp. 101-185. ISSN 1323-7799 (2016) [Conference Extract] DOI: 10.1111/resp.12755 [eCite] [Details] Co-authors: Bereznicki BJ; Walters EH; Walters JAE; Peterson GM | |
| 2016 | Frain BE, Castelino R, Bereznicki LRE, 'The Utilisation of Antithrombotic Therapy in Older Patients in Aged Care Facilities with Atrial Fibrillation', APSA Annual Conference 2016, 2-5 December, 2016, Sydney, Australia (2016) [Conference Extract] Co-authors: Frain BE; Castelino R | |
| 2016 | Obamiro KO, Rolls CA, Chalmers L, Bereznicki LRE, 'The relationship between anticoagulation knowledge, health literacy and medication adherence in patients with atrial fibrillation', APSA Annual Conference 2016, 2-5 December 2016, Sydney, Australia (2016) [Conference Extract] Co-authors: Obamiro KO; Chalmers L | |
| 2016 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Peterson GM, et al., 'Adverse drug reaction-related hospitalisation in older patients - A prospective analysis in two hospitals', APSA Annual Conference 2016, 2-5 December, 2016, Sydney, Australia (2016) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain CM; Peterson GM; Connolly MJ | |
| 2016 | Veal F, Thompson A, Bereznicki L, Peterson G, 'Persistent post-operative pain and its influence on preoperative pain management', International Association for the Study of Pain 16th biannual World Congress on Pain, 26-30 September, Yokohama, Japan (2016) [Conference Extract] Co-authors: Veal F; Thompson A; Peterson G | |
| 2015 | Bereznicki BJ, Walters EH, Walters JAE, Peterson GM, Bereznicki LRE, 'Diagnosis and management of early COPD in Australia: views from the coal face', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bereznicki BJ; Walters EH; Walters JAE; Peterson GM | |
| 2015 | Bernal D, Chalmers L, Castelino RL, Bereznicki LRE, Peterson GM, 'Home Medicines Review following acute coronary syndromes: Preliminary results from a randomised controlled trial', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bernal D; Chalmers L; Castelino RL; Peterson GM | |
| 2015 | Bezabhe W, Chalmers L, Bereznicki LRE, Gee PR, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM | |
| 2015 | Bezabhe W, Chalmers L, Bereznicki LRE, Gee PR, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM | |
| 2015 | Bindoff IK, Ling TR, Bereznicki LRE, Chalmers L, Westbury JL, 'Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bindoff IK; Ling TR; Chalmers L; Westbury JL | |
| 2015 | Bindoff IK, Ling TR, Bereznicki LRE, Chalmers L, Westbury JL, et al., 'Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists', Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bindoff IK; Ling TR; Chalmers L; Westbury JL; Gee PR; Garland T | |
| 2015 | Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bista D; Chalmers L; Peterson GM | |
| 2015 | Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bista D; Chalmers L; Peterson GM | |
| 2015 | Chalmers L, Bereznicki LRE, Prasad R, Hancock N, MacIntyre PD, et al., 'SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Chalmers L; Frain BE | |
| 2015 | Chalmers L, Bereznicki LRE, Prasad Ritam, Hancock N, MacIntyre PD, et al., 'SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Chalmers L; Prasad Ritam; Frain BE | |
| 2015 | Chalmers L, Scott BE, Curtain CM, Bereznicki LRE, 'Tasmanian hospital clinicians' attitudes regarding stroke prevention in atrial', Medicines Management 2015: The 41st SHPA National Conference, 3-6 December, 2015, Melbourne, Australia, pp. 82. (2015) [Conference Extract] Co-authors: Chalmers L; Curtain CM | |
| 2015 | Chapman M, Bereznicki BJ, Bereznicki LRE, 'Understanding the discrepancy between perceived and actual asthma control in Australia', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bereznicki BJ | |
| 2015 | Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Obamiro KO; Chalmers L | |
| 2015 | Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Obamiro KO; Chalmers L | |
| 2015 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Castelino RL, Peterson GM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Castelino RL; Peterson GM; Curtain CM; Connolly MJ | |
| 2015 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Peterson GM, Curtain CM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Bereznicki BJ; Peterson GM; Curtain CM; Connolly MJ | |
| 2015 | Scott BE, Curtain CM, Chalmers L, Bereznicki LRE, 'Clinicians' attitudes and perceptions regarding stroke prevention in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Curtain CM; Chalmers L | |
| 2015 | Scott BE, Curtain CM, Chalmers L, Bereznicki LRE, 'Clinicians' attitudes and perceptions regarding stroke prevention in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Curtain CM; Chalmers L | |
| 2014 | Chalmers L, Nash RE, Holmes SE, Bereznicki LRE, Cooper J, et al., 'Development of a benchmarking tool for pharmacy students using threshold learning outcomes', APSA 2014 Annual Conference, 5-7 December, 2014, Brisbane, Australia (2014) [Conference Extract] Co-authors: Chalmers L; Nash RE; Holmes SE | |
| 2014 | Chalmers L, Nash RE, Holmes SE, Bereznicki LRE, Rasiah Rohan, et al., 'Development of a benchmarking tool for pharmacy students using threshold learning outcomes', Teaching Matters 2014, 2-3 December, 2014, Hobart, Tasmania (2014) [Conference Extract] Co-authors: Chalmers L; Nash RE; Holmes SE; Rasiah Rohan | |
| 2014 | Thompson A, Bereznicki L, Francis H, Lee S, McKenzie D, et al., 'Adverse effects associated with gabapentinoids in persistent pain', Pharmacy Australia Congress, 10-12 October, Canberra, Australia (2014) [Conference Extract] Co-authors: Thompson A; Francis H; Lee S; Peterson G; Veal F | |
| 2014 | Veal F, Thompson A, Perry L, Bereznicki L, Peterson G, 'Management of pain in surgical patients post discharge - who is responsible for the provision of advice?', International Association for the Study of Pain 16th biannual World Congress on Pain, 26-30 September, Yokohama, Japan (2014) [Conference Extract] Co-authors: Veal F; Thompson A; Peterson G | |
| 2014 | Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE, 'The effect of knowledge and expectations on adherence to and persistence with antidepressants', APSA 2014 Annual Conference, 5-7 December, 2014, Brisbane, Australia (2014) [Conference Extract] Co-authors: Woodward SC; Bereznicki BJ; Westbury JL | |
| 2013 | Thompson A, Bereznicki B, Francis H, Lee S, McKenzie D, et al., 'Patient experiences with gabapentinoid therapy for persistent pain', Proceedings of the Australasian Pharmaceutical Science Association Conference, 8-11 December, Dunedin, New Zealand (2013) [Conference Extract] Co-authors: Thompson A; Francis H; Lee S; Peterson G; Peterson C; Veal F | |
| 2013 | Veal F, Bereznicki L, Peterson G, Thompson A, 'Opioid use in community dwelling elderly in Australia', 5th Association of South-East Asian Pain Societies Conference, 2-5 May, Singapore (2013) [Conference Extract] Co-authors: Veal F; Peterson G; Thompson A | |
| 2013 | Veal F, Bereznicki L, Peterson G, Thompson A, 'Opioid use in elderly community and nursing home patients', 5th Association of South-East Asian Pain Societies Conference, 2-5 May, Singapore (2013) [Conference Extract] Co-authors: Veal F; Peterson G; Thompson A | |
| 2013 | Veal F, Bereznicki L, Peterson G, Thompson A, 'Opioid use in Australian nursing home residents', 5th Association of South-East Asian Pain Societies Conference, 2-5 May, Singapore (2013) [Conference Extract] Co-authors: Veal F; Peterson G; Thompson A | |
| 2011 | Bereznicki LRE, 'Atrial fibrillation: keeping the beat', Pharmacy Expo 2011 catalogue, 17-19 June 2011, Darling Harbour NSW, Australia, pp. 28. ISBN 0 000 00000 0 (2011) [Plenary Presentation] | |
| 2011 | Bereznicki LRE, 'Point of Care INR Monitoring', Pharmacy Expo 2011 catalogue, 17-19 June 2011, Darling Harbour NSW, Australia, pp. 29. ISBN 0 000 00000 0 (2011) [Plenary Presentation] | |
| 2011 | Bereznicki LRE, Chalmers L, Van Tienen EC, 'The current status of veterans taking warfarin', not known, 30 October- 2 November, Sydney NSW Australia, pp. 145. (2011) [Conference Extract] Co-authors: Chalmers L; Van Tienen EC | |
| 2011 | McNamara K, Stewart K, George J, Jackson SL, Peterson GM, et al., 'Efficacy of a Pharmacist-Managed Intervention for Improved Blood Pressure Control in Patients with Elevated Cardiovascular Disease Risk: Subgroup Analysis of the HAPPY RCT', Heart Lung and Circulation, 11-14 August 2011, Perth, Australia, pp. 54. ISBN 0-000-00000-0 (2011) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Gee PR | |
| 2011 | Norton L, Bereznicki BJ, Bereznicki LRE, Beggs S, 'A review of the management of childhood asthma in Tasmania', APSA 2011 Annual Conference, 11-14 December, 2011, Adelaide, Australia (2011) [Conference Extract] Co-authors: Bereznicki BJ; Beggs S | |
| 2011 | Stafford L, Bereznicki LRE, Wang G, 'Barriers to INR self-monitoring in mechanical heart valve recipients: a qualitative study', Medicines Management Conference Handbook 2011, 10-13 November 2011, Hobart Tasmania Australia, pp. 169. (2011) [Conference Extract] Co-authors: Stafford L | |
| 2011 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'Clinical outcomes of a pharmacist-led post-discharge warfarin management service', Proceedings of the 11th national conference on anticoagulant therapy, 5-7 May 2011, Sheraton Boston Hotel, Boston, MA, USA, pp. 370. (2011) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL | |
| 2011 | Van Tienen EC, Stafford L, Bereznicki LRE, Peterson GM, 'Patient self-monitoring of anticoagulation: a follow-up study', Proceeding of the 11th national conference on anticoagulant therapy, 5-7 May 2011, Sheraton Boston Hotel, Boston, MA , pp. 382. (2011) [Conference Extract] Co-authors: Van Tienen EC; Stafford L; Peterson GM | |
| 2010 | Bereznicki LRE, 'Practical aspects of anti-platelet therapy', AACP's 6th annual consultant pharmacy clinical seminar handbook, 29-31 May 2010, The Hotel Grand Chancellor Hobart Tasmania (2010) [Conference Extract] | |
| 2010 | Bereznicki LRE, 'INR and practical patient care', Pharmacy Expo 2010 Catalogue, 4-6 June 2010, Sydney Convention and Exhibition Centre, Sydney, pp. 23. (2010) [Conference Extract] | |
| 2010 | Bereznicki LRE, 'Pharmacy based model enabling patient self monitoring of warfarin: Development and evaluation', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 10. (2010) [Conference Extract] | |
| 2010 | Bereznicki LRE, 'Outcomes of a Pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract] | |
| 2010 | Bereznicki LRE, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 78. (2010) [Conference Extract] | |
| 2010 | Bereznicki LRE, 'Attempting to change practice: challenges and rewards', The 36th SHPA National Conference 2010 handbook, 11-14 November 2010, Melbourne Convention Exhibition Centre, pp. 83. (2010) [Conference Extract] | |
| 2010 | George J, McNamara K, Jackson SL, Hughes J, Peterson GM, et al., 'The HAPPY Trial: a community pharmacy - based intervention for improving patient adherence to antihypertensive medicines', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 79. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Gee PR | |
| 2010 | Jackson SL, Peterson GM, Bereznicki LRE, Gee PR, 'Hypertension adherence program in pharmacy (HAPPY Trial): Methodology', Pharmacy Practice Research Summit 2010, 2-4 March 2010, Rydges Lakeside, Canberra, pp. 18. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Gee PR | |
| 2010 | Jackson SL, Peterson GM, Bereznicki LRE, Gee PR, 'Hypertension adherence program in pharmacy (HAPPY trial): Baseline data', Pharmacy Practice Research Summit 2010, 2-4 March 2010, Rydges Lakeside, Canberra, pp. 18. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Gee PR | |
| 2010 | Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, Jupe D, et al., 'Ensuring accurate results in INR self-monitoring', Pathology The Journal of the Royal College of Pathologists of Australasia, 2010, Melbourne Convention Centre, pp. 70. (2010) [Conference Extract] Co-authors: Jeffrey EC; Stafford L; Peterson GM | |
| 2010 | Mirkazemi C, Bereznicki LRE, Peterson GM, 'Thromboprophylaxis following arthroplasty surgery', 2010 National conference of emerging researchers in ageing abstracts and proceedings, 21-22 October 2010, Newcastle City Hall, pp. 41. (2010) [Conference Extract] Co-authors: Mirkazemi C; Peterson GM | |
| 2010 | Mirkazemi C, Peterson GM, Bereznicki LRE, 'Thromboprophylaxis and venous thromboembolism following lower limb orthopaedic surgery at an Australian hospital', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 180. (2010) [Conference Extract] Co-authors: Mirkazemi C; Peterson GM | |
| 2010 | Peterson GM, Stafford L, Bereznicki LRE, Jackson SL, 'Short-term outcomes of usual care in patients taking warfarin after discharge from hospital', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 18. (2010) [Conference Extract] Co-authors: Peterson GM; Stafford L; Jackson SL | |
| 2010 | Peterson GM, Stafford L, Bereznicki LRE, van Tienen EC, Jackson SL, 'The role of community pharmacy in post hospital management of patients initiated on warfarin', Pharmacy Practice Research Summit Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 14. (2010) [Conference Extract] Co-authors: Peterson GM; Stafford L; van Tienen EC; Jackson SL | |
| 2010 | Stafford L, DeBoos I, Peterson GM, Bajorek B, Jackson SL, et al., 'A qualitative analysis of warfarin management after discharge from hospital', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 18. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, 'Outcomes of a pharmacist-led post discharge warfarin management service: adverse events, warfarin knowledge and patient satisfaction', SEiR 2010 Postgraduate Research Conference booklet, 16-17 November 2010, University of Tasmania, Hobart Tasmania, pp. 32. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Jainullabudeen TA, et al., 'Clinical outcomes and cost-effectiveness of a pharmacy-led post-discharge warfarin management service', Proceeding of the Australasian Pharmaceutical Science Association Annual Conference 2010, 6-9 December 2010, Woolloongabba, QLD, pp. 81. ISBN 978-0-646-54805-0 (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL; Bindoff IK | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, van Tienen EC, et al., 'How can pharmacists improve warfarin management along the continuum of care?', The 36th SHPA National Conference 2010 handbook, 11-14 November 2010, Melbourne Convention Exhibition Centre, pp. 196. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL; van Tienen EC | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress 2010 - Program handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 78. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service adverse events, warfarin knowledge and patient satisfaction', Society of Hospital Pharmacists of Australia 2010 Tasmanian Branch Symposium, 21-23 May 2010, Port Arthur, Tasmania (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 194. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL | |
| 2010 | Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 265. (2010) [Conference Extract] Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL | |
| 2010 | Van Tienen EC, Bereznicki LRE, Peterson GM, 'A flexible anticoagulation monitoring service for rural community pharmacies: A pilot study', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract] Co-authors: Van Tienen EC; Peterson GM | |
| 2010 | Van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Development of www.anticoagulation.com.au - A resource for anticoagulation therapy', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 76. (2010) [Conference Extract] Co-authors: Van Tienen EC; Stafford L; Peterson GM | |
| 2010 | Van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Consumer perspectives on INR self-monitoring', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 76. (2010) [Conference Extract] Co-authors: Van Tienen EC; Stafford L; Peterson GM | |
| 2010 | van Tienen EC, Bereznicki LRE, Peterson GM, 'A flexible anticoagulation monitoring service for rural community pharmacies: a pilot study', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 272. (2010) [Conference Extract] Co-authors: van Tienen EC; Peterson GM | |
| 2010 | van Tienen EC, Bereznicki LRE, Peterson GM, 'Development of wwww.anticoagulation.com.au - a resource for anticoagulation therapy', Pharmacy Practice Reseach Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra, pp. 19. (2010) [Conference Extract] Co-authors: van Tienen EC; Peterson GM | |
| 2010 | van Tienen EC, Bereznicki LRE, Peterson GM, Stafford L, 'Evaluation of a clinical pathway to enable patient self-monitoring of warfarin', Pharmacy Practice Reseach Summit 2010 Program, 2-4 march 2010, Rydges lakeside Canberra, pp. 19. (2010) [Conference Extract] Co-authors: van Tienen EC; Peterson GM; Stafford L | |
| 2010 | van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation ', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 77. (2010) [Conference Extract] Co-authors: van Tienen EC; Stafford L; Peterson GM | |
| 2010 | van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Consumer perspectives on INR self-monitoring', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 270. (2010) [Conference Extract] Co-authors: van Tienen EC; Stafford L; Peterson GM | |
| 2010 | van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Development of www.anticoagulation.com.au - a resource for anticoagulation therapy', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 271. (2010) [Conference Extract] Co-authors: van Tienen EC; Stafford L; Peterson GM | |
| 2010 | van Tienen EC, Stafford L, Bereznicki LRE, Peterson GM, 'Patient self-monitoring of anticoagulation: a follow up study', HAA Annual Scientific Meeting Handbook and Programme, 17-20 October, Sky City Convention Centre, pp. A235. (2010) [Conference Extract] Co-authors: van Tienen EC; Stafford L; Peterson GM | |
| 2009 | Bereznicki LRE, 'Antithrombotics: How pharmacists can optimise outcomes', Pharmacy Expo 2009 Catalogue, 12-14 June 2009, Sydney Convention and Exhibition Centre, Sydney, pp. 19. (2009) [Conference Extract] | |
| 2009 | Bereznicki LRE, 'INR point of care testing', The Australian Institute of Medical Scientists, 8-9 August 2009, The Colonial on Elizabeth, Launceston, pp. 6. (2009) [Conference Extract] | |
| 2009 | Bereznicki LRE, 'Anticoagulation patient self-monitoring', The Pharmacy Australia Congress Program Handbook, 15-18 October 2009, The Sydney Hilton, Sydney Australia, pp. 64. (2009) [Conference Extract] | |
| 2009 | Bereznicki LRE, 'Therapeutic Update: Warfarin', The AACP Accredited Pharmacists Forum 2009, 15-18 October 2009, Sydney Hilton, Sydney Australia, pp. xx-xx. (2009) [Conference Extract] | |
| 2009 | Bereznicki LRE, 'How can pharmacists improve the management of warfarin therapy?', In: APSA 2009 : Out of the wilderness : Proceedings of the Australasian Pharmaceutical Science Association annual conference 2009 , 9 - 11 December 2009, Wrest Point Convention Centre, Hobart Tasmania, pp. 62. ISBN 978-0-646-52257-9 (2009) [Conference Extract] | |
| 2009 | Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation', HAA handbook and final programme, 19-21 October, Adelaide Australia, pp. 276. (2009) [Conference Extract] Co-authors: Jeffrey EC; Stafford L; Peterson GM | |
| 2009 | Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Refinement of an innovative web-based anticoagulation resource', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, pp. 73. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Jeffrey EC; Stafford L; Peterson GM | |
| 2009 | Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 153. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Jeffrey EC; Stafford L; Peterson GM | |
| 2009 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'Characteristics and short-term outcomes of Royal Hobart Hospital patients discharged on warfarin', Society of Hospital Pharmacists of Australia, Tasmanian Branch, Symposium 2009, 22-24 May 2009, Grindelwald, Tasmania (2009) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL | |
| 2009 | Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Bajorek B, et al., 'More blood, sweat and tears: a qualitative analysis of warfarin management after discharge from hospital', SHPA 35th National Conference Handbook and book of abstracts, 5-8 November 2009, Perth Convention Exhibition Centre WA, pp. 184. (2009) [Conference Extract] Co-authors: Stafford L; Peterson GM; Jackson SL | |
| 2009 | Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Early outcomes of a pharmacist-led post-discharge warfarin management service', The Australasian Pharmaceutical Science Association Annual Conference Program and Abstract Booklet , 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 81. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL | |
| 2009 | Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'Identifying barriers to the implementation of an electronic system designed for documenting clinical interventions within community pharmacies ', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 176. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Williams Mackenzie; Peterson GM; Tenni PC | |
| 2009 | Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'Refinement of the design of an electronic system to record community pharmacy interventions', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet , 9-11 December 2009 , Wrest Point Convention Centre, Hobart, Tasmania , pp. 175. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Williams Mackenzie; Peterson GM; Tenni PC | |
| 2008 | Bereznicki LRE, 'Innovative communication strategies to manage chronic disease or high-risk medications', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 29. (2008) [Conference Extract] | |
| 2008 | Bereznicki LRE, Peterson GM, Krog M, La Rosa T, Marsden KA, et al., 'The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 96. (2008) [Conference Extract] Co-authors: Peterson GM; Krog M; La Rosa T; Marsden KA; Lowenthal RM | |
| 2008 | Bereznicki LRE, Peterson GM, Krog M, La Rosa T, Marsden KM, 'The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract] Co-authors: Peterson GM; Krog M; La Rosa T; Marsden KM | |
| 2008 | Jackson SL, Bereznicki LRE, Gee PR, Fitzmaurice KD, Kromdijk W, et al., 'Innovative IT solutions to improve the management of warfarin', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 60. (2008) [Conference Extract] Co-authors: Jackson SL; Gee PR; Fitzmaurice KD; Kromdijk W; Bereznicki BJ; Marsden KA | |
| 2008 | Jeffrey EC, Bereznicki LRE, Peterson GM, Jackson SL, 'Development of an innovative web based anticoagulation resource', Teams for tomorrow - Proceedings of the APSA (Australasian Pharmaceutical Science Association), 6-9 December 2008, Canberra, ACT, pp. 108. ISBN 0-646-44244-9 (2008) [Conference Extract] Co-authors: Jeffrey EC; Peterson GM; Jackson SL | |
| 2007 | Bereznicki LRE, 'New Investigator Presentations: Improving the quality use of anticoagulants', Pharmacy Congress: Good Pharmacy , Better Health & health Industry Forum Program and Handbook, 23-26 August 2007, Melbourne, Aust, pp. 60. (2007) [Conference Extract] | |
| 2007 | Bereznicki LRE, 'A pilot study of warfarin home monitoring with electronic communication to primary care', Australian Disease Management Association Full Program, 6-7 September 2007, Melbourne, Aust, pp. 20. (2007) [Conference Extract] | |
| 2007 | Bereznicki LRE, Jackson SL, Peterson GM, 'A pilot study of warfarin home-monitoring with electronic communication to primary care', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited] Co-authors: Jackson SL; Peterson GM | |
| 2007 | Bereznicki LRE, Jackson SL, Ripley A, 'INR Self Monitoring Training Workshop', INR Self Monitoring Training Workshop, 3 June 2007, Sunshine Coast, Qld, Aust, pp. 200. (2007) [Non Refereed Conference Paper] Co-authors: Jackson SL | |
| 2007 | Peterson GM, Jackson SL, Gee PR, Bereznicki LRE, Bereznicki BJ, et al., 'Improving the management of warfarin in aged care facilities utilising an innovative IT solution', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited] Co-authors: Peterson GM; Jackson SL; Gee PR; Bereznicki BJ; Fitzmaurice KD; Kromdijk W | |
| 2006 | Bereznicki LRE, 'An intervention to improve clinical outcomes for inpatients commenced on warfarin', The Society of Hospital Pharmacists of Australia Program Handbook, 9-11 November 2006, Telstra Dome Melbourne, pp. 88. (2006) [Conference Extract] | |
| 2006 | Bereznicki LRE, 'Thromboprophylaxis in medical patients', The Society of Hospital Pharmacists of Australia Program Handbook, 9-11 November 2006, Telstra Dome Melbourne, pp. 38. (2006) [Conference Extract] | |
| 2006 | Bereznicki LRE, Burbury K, Jupe DM, Marsden KA, Hancock N, et al., 'Improving the use of prophylaxis for venous thromboembolism at the Royal Hobart Hospital', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 50. (2006) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Vial JH | |
| 2006 | Bereznicki LRE, Jackson SL, Boland C, Marsden KA, Voute J, et al., 'An intervention to improve adherence to an initiation protocol and improve clinical outcomes for patients commenced on warfarin', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 36. (2006) [Conference Extract] Co-authors: Jackson SL; Vial JH; Peterson GM | |
| 2006 | Bereznicki LRE, Jackson SL, Peterson GM, Jeffrey EC, Leong K, et al., 'The warfarin home-monitoring pilot study', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 35. (2006) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Jeffrey EC | |
| 2006 | Peterson GM, Jackson SL, Tompson AJ, Bereznicki LRE, 'An evaluation of pharmacist-assisted anticoagulant monitoring after initiation of warfarin in the transition from hospital to community care', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 36. (2006) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Tompson AJ | |
| 2005 | Bereznicki LRE, Jackson SL, Vlassak E, Burbury K, Marsden KM, et al., 'The use of thromboprophylaxis for venous thromboembolism (VTE) in hospitalised medical patients', HSANZ/ANZSBT/ASTH Annual Scientific Meeting, 16-19 October 2005, Sydney Convention and Exhibition Centre, Darling H, pp. 107. (2005) [Conference Extract] Co-authors: Jackson SL; Vlassak E; Peterson GM | |
| 2005 | Bereznicki LRE, Vlassak E, Peterson GM, Jackson SL, Marsden K, et al., 'The use of thromboprophylaxis for venous thromboembolism in hospitalised medical patients at the Royal Hobart Hospital', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract] Co-authors: Vlassak E; Peterson GM; Jackson SL; Vial JH | |
| 2005 | Boland C, Aldous D, Bereznicki LRE, Vial JH, Marsden K, et al., 'Reducing harm associated with warfarin therapy: a national medication safety collaborative project', Conference Handbook and Proceedings, 10-13 November 2005, Brisbane, Qld, pp. 87. ISSN 1833-0169 (2005) [Conference Extract] Co-authors: Vial JH | |
| 2005 | Boland C, Aldous D, Bereznicki LRE, Vial JH, Marsden KM, et al., 'Reducing harm associated with warfarin therapy. A national medication safety breakthrough project', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract] Co-authors: Vial JH; Marsden KM | |
| 2005 | Jackson SL, Bereznicki LRE, Peterson GM, Fitch J, Fowler P, 'Review of the initiation of warfarin in Tasmania', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract] Co-authors: Jackson SL; Peterson GM | |
| 2004 | Jackson SL, Morgan S, Peterson GM, Bereznicki LRE, Jupe DML, et al., 'A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?', Conference Handbook, 29-31 October 2004, Sydney, pp. 79. (2004) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Marsden KA | |
| 2004 | Jackson SL, Peterson GM, Morgan S, Bereznicki LRE, Jupe DML, 'A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?', Handbook and Final Programme. Advancing Haematology Through Science, 17-20 October 2004, Melbourne, Victoria, pp. 308. (2004) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Jupe DML |
Thesis
(1 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2007 | Bereznicki LRE, 'Improving the quality use of anticoagulants' (2007) [PhD] |
Grants & Funding
Funding Summary
Number of grants
45
Total funding
Projects
- Description
- Blood clots are a serious and often life-threatening complication of cancer that can be largely avoided with appropriate care. We will review preventative practices used locally, as well as associated influences, with the aim to optimise care and reduce this risk in future Tasmanians diagnosed with cancer.
- Funding
- Royal Hobart Hospital Research Foundation ($9,497)
- Scheme
- Grant-Incubator
- Administered By
- Tasmanian Health Service
- Research Team
- Batt T; Mirkazemi C; Peterson GM; Bereznicki LRE
- Year
- 2021
- Description
- Dementia is a significant risk factor for serious side effects of medicines or adverse drug reactions (ADRs). This prospective study will investigate and identify the prevalence and risk factors for ADR-related hospital admissions in elderly patients with dementia or cognitive impairment.
- Funding
- Royal Hobart Hospital Research Foundation ($9,985)
- Scheme
- Grant-Incubator
- Administered By
- University of Tasmania
- Research Team
- Parameswaran Nair N; Bereznicki LRE; Adamczewski B; Salahudeen MS; Bereznicki BJ
- Year
- 2020
- Description
- Based on our prospective adverse drug reaction (ADR) registry:1*15% of medical admissions to Tasmanian public hospitals in elderly patients were ADR-related,*89% were preventable,*17% patients had a repeat ADR within 12 months, and*One third of patients with repeat ADRs experienced the same ADR caused by the same medications.From this clinical registry, we developed and validated an ADR risk prediction score (PADR-EC).2We hypothesise that ADR risk stratification during hospitalisation and communication of this risk, together with recommendations that target the specific risk factors identified, to GPs at discharge will reduce the risk of ADR-related hospitalisation.Design: A randomised controlled trial (RCT) at the Royal Hobart Hospital, the major public hospital in Tasmania.Population: Over 12-months, 1000 patients ≥65 years with unplanned admissions to medical wards will be recruited and randomly allocated to intervention or control groups.Intervention: A researcher will perform an ADR risk assessment using the PADR-EC Score,2 which is the sum of points assigned to 5 independent predictors of ADR-related hospitalisation. Based on the PADR-EC Score and the specific risk factors identified, recommendations to reduce the risk of ADRs will be determined.Recommendations will relate to:*post-discharge medication management services, *monitoring of specific parameters/medications, and *de-prescribing strategies.The PADR-EC Score and recommendations will be communicated to the patient and clinical team during hospitalisation, and the patient's GP, alongside the usual information, in the electronic discharge summary. Control: Usual hospital care, with GPs receiving the standard discharge summary.Follow up: All participants will be followed by the research team for 12-months to identify ADRs (including their management and outcome) and health services received.Outcomes: ADR-related hospitalisation (primary); ADRs requiring hospital treatment, change in therapy or specific treatment (secondary). The study will be powered to detect a 5% difference in the primary outcome
- Funding
- HCF Health and Medical Research Foundation ($274,000)
- Scheme
- Grant-Health Services Research Program
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Curtain CM; Bereznicki BJ; Cousins JM; Connolly MJ; Adamczewski B; McKenzie D; Simpson T; Barratt A; Webber E; Parameswaran Nair N
- Period
- 2019 - 2022
- Description
- The project is a retrospective audit of thromboprophylaxis prescribing for hip and knee arthroplasty patients who have undergone (or will undergo) surgery at the RHH between June 2017 and June 2019.
- Funding
- Royal Hobart Hospital Research Foundation ($9,791)
- Scheme
- Grant-Incubator
- Administered By
- University of Tasmania
- Research Team
- Mirkazemi C; Peterson GM; Bereznicki LRE; Batt T
- Year
- 2019
- Description
- This randomised controlled trial will assess a pharmacist led intervention to reduce medicine induced deterioration and adverse reactions. Medicine induced deterioration encompasses the spectrum of side effects that are frequently not recognised as medication related but are misattributed as geriatric syndromes, frailty or changes due to aging. The aim of the service is to enable early identification of signs and symptoms of medicine- induced deterioration so that worsening frailty and subsequent adverse events, such as injurious falls, fractures and delirium are prevented. In implementing the service, the pharmacist will use a suite of validated tools to assist in the detection of signs and symptoms of medicine-induced deterioration. The validated tools will encompass assessments to monitor changes in cognition, change in 24-hour movement behavior, including sleep, as well as grip strength. In addition, pharmacists will assess the potential for adverse medicine events via review of the resident care assessment record and through patient or carer reported changes in health since the medicine regimen was changed. The pharmacist service will be compared with usual care. The trial, involving 500 patients will take place in aged-care facilities in South Australia and Tasmania. Evaluation will encompass health program, clinical and economic evaluation. The expected clinical outcome is a reduction in medication-induced deterioration, as measured by change in frailty score. Adverse events will be measured as a secondary outcome. The cost- effectiveness evaluation will assess cost per adverse event avoided.
- Funding
- Department of Health (Cth) ($2,847,927)
- Scheme
- Pharmacy Trial Program (Tranche 2)
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Roughead L; Pratt N; Parfitt G; Cousins JM; Williams M
- Period
- 2018 - 2020
- Description
- Stroke continues to be a major public health issue. It is the third most common cause of death. The financial cost in Australia is estimated to be $5 billion each year. Tasmania and South Australia are the worst affected States. Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is a major modifiable risk factor for stroke. AF is associated with a five times increased risk of stroke and is responsible for up to 25% of strokes in elderly adults. Recently, international guidelines and expert consensus statements have recommended more widespread screening for AF in those aged 65 years or older. The case is compelling - AF is common and a leading cause of stroke. Unfortunately, AF often has no symptoms and is commonly undiagnosed or untreated by the time stroke occurs. AF-related strokes are associated with significant morbidity, mortality, and healthcare costs, yet they are highly preventable with the use of warfarin or newer anticoagulant drugs. Given the availability of effective therapy, along with accurate and inexpensive screening technology, population-based AF screening has the potential to become an important public health program. In older age groups, identification and management of AF is the most significant way to prevent stroke.Internationally, there have been recent recommendations for more widespread screening for AF in those aged 65 years or older, as a cost-effective strategy for stroke prevention. This project will raise public awareness of AF and improve its detection, and subsequently lessen the burden of stroke in Tasmania. We intend to screen approximately 3,000 Tasmanians aged 65 years or older, and without previously diagnosed AF. Screening will take place throughout most of 2018 at a range of community venues across Tasmania.
- Funding
- Tasmanian Community Fund ($69,182)
- Scheme
- Grant
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Wimmer BC; Bereznicki LRE; Macintyre K; Khanam MA; Black JA; Radford JC; Dwan C
- Year
- 2018
- Description
- We will conduct a cluster randomised trial, with asthma control being the main inclusion criterion and clinical outcome measured. The three study arms are: Group A (Pharmacy Asthma Service): eligible patients will receive four private consultations with the pharmacist, at baseline, one month, six months (via telephone) and 12 months. The consultations will focus on addressing three key factors associated with uncontrolled asthma: suboptimal adherence characterised by underuse of preventer medication and/or overuse of reliever medication; suboptimal inhaler technique; and/or uncontrolled allergic rhinitis. At each visit, asthma control and a number of secondary outcomes will be assessed. Group B (Low intervention and referral): Patients identified with uncontrolled asthma by the pharmacist will be referred to their general practitioner. Clinical outcomes will be assessed at one month and 12 months. Group C (Usual Care): The third group will be recruited from a comparable sample of patients with asthma, matched by age, gender and asthma control scores from general practice medical records. Asthma control and secondary outcomes for this group will be assessed by the project group at baseline and 12 months.
- Funding
- Department of Health (Cth) ($2,074,100)
- Scheme
- Pharmacy Trial Program (Tranche 2)
- Administered By
- Woolcock Institute of Medical Research
- Research Team
- Armour C; Krass I; Bosnic-Anticevich S; Saini B; Bereznicki LRE; Bereznicki BJ; Emmerton L
- Period
- 2017 - 2020
- Description
- Chronic opioid use for persistent pain is skyrocketing and is associated with substantial patient harm. This study will review what the risk of chronic opioid use is following a supply of an opioid at discharge from the Royal Hobart Hospital and make recommendations to improve the way opioids are prescribed.
- Funding
- Royal Hobart Hospital Research Foundation ($9,233)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Veal FC; Bereznicki LRE; Thompson AJ; Orlikowski C; Boyles PJ; Halliday SW; Huckerby E
- Year
- 2017
- Description
- The project is designed to educate medical representatives from pharmaceutical companies to a recognised industry standard and is a compulsory requirement for all professionals working in this area. The contract also contains specific research objectives.
- Funding
- Medicines Australia ($1,200,000)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Dwan C; Ling TR; Bindoff IK; Gee PR
- Period
- 2016 - 2018
- Description
- This project will describe the presentations to the Royal Hobart Hospital emergency department by children with fever, investigate the knowledge, beliefs and perceptions about childhood fever among parents and caregivers in Tasmania, and develop an educational package for parents and caregivers about childhood fever.
- Funding
- Royal Hobart Hospital Research Foundation ($9,599)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Bereznicki BJ; Beggs S; Bereznicki LRE; Zosky GR
- Year
- 2016
- Description
- This project will ensure that resources and training are provided for examiners to produce a reliable and consistent training process that will ensure candidates are reliably assessed on their ability to demonstrate that they can work safely, professionally and ethically unsupervised.
- Funding
- University of Newcastle ($14,033)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Chalmers L; Rasiah R; Cooper J
- Year
- 2015
- Description
- The objectives of this study are to:*Develop and validate a decision support smartphone application ('app') to support prescribers in the choice of thromboprophylaxis in patients with atrial fibrillation (AF),*Evaluate the effect of the tool on prescriber confidence in choosing antithrombotic agents for patients with AF based on patient age, comorbidities, concomitant drug therapy and other characteristics, and*Evaluate the effect of the tool on the prescribing patterns of antithrombotic therapy in patients admitted to the RHH with AF.
- Funding
- Royal Hobart Hospital Research Foundation ($12,000)
- Scheme
- Grant-Clinical Research
- Administered By
- University of Tasmania
- Research Team
- Chalmers L; Bereznicki LRE; Prasard R; Hancock N; MacIntyre P; McKenzie D; Boland C
- Year
- 2015
- Description
- G4HEALTH will develop a digital game platform that will enable University of Tasmania researchers, in collaboration with industry partners, to provide a benefit for the community, and place the University at the forefront of the billion dollar games for health industry. Platform and game development will involve a cross-disciplinary community of researchers with expertise from engineering, science, education, and health through to arts. It will consist of off-the-shelf sensors and devices capable of measuring physical activity, providing feedback, delivering narrative-driven games to encourage activity, and transmitting the resulting data. Technologies identified and games and story developed will be used in two proposed intervention studies to increase engagement in physical activity by older adults, people living with chronic disease and adults in a workplace setting in the North of Tasmania. The project will position the University of Tasmania at the forefront of National activities in the Games for Health space and is aligned with the Tamar Health concept.
- Funding
- University of Tasmania ($250,000)
- Scheme
- Grant-Strategic Research
- Administered By
- University of Tasmania
- Research Team
- Smith SS; Peterson GM; Bereznicki LRE; Loo S; Maxwell-Stewart HJ
- Period
- 2015 - 2016
- Description
- This project aims to investigate if community pharmacy screening and intervention helps improve the management of kidney disease, which has been increasing steadily in Tasmania.
- Funding
- Tasmanian Community Fund ($26,775)
- Scheme
- Grant
- Administered By
- University of Tasmania
- Research Team
- Castelino RL; Peterson GM; Bereznicki LRE; Razi Zaidi ST; Jose MD
- Year
- 2014
- Description
- Atrial fibrillation (AF) is a common heart arrhythmia, which affects approximately 2% of all Australians, and almost 10% of people over the age of 75 years. AF is associated with a 5-fold increase in the risk of stroke. Anticoagulant therapies like warfarin, dabigatran, rivaroxaban and apixaban are highly effective in reducing the risk of stroke associated with AF, but also place patients at risk of bleeding adverse events. It is therefore critical that anticoagulant therapies are used appropriately in people with AF, to ensure that the right patients receive them and that the risk of bleeding is kept as low as possible. This project will enable Tasmanians taking anticoagulant therapy access to high quality, independent educational resources focussed on improving the use of this commonly used but high-risk group of medications. The project is focussed on developing educational resources for people taking the commonly used anticoagulant drug warfarin, and three new anticoagulant medications (dabigatran, rivaroxaban and apixaban). These medicines are used to prevent stroke in people with atrial fibrillation, as well as prevent and treat deep vein thrombosis and pulmonary embolism. Given the demographics of Tasmania's community, the use of these medicines and need for relevant educational support of consumers is highest in this State. The project will develop educational tools for consumers and health professionals, and promote these resources to general practices and community pharmacies.
- Funding
- Tasmanian Community Fund ($10,435)
- Scheme
- Grant
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Chalmers L; Peterson GM; van Tienen EC
- Year
- 2013
- Description
- This project is a prospective, cross sectional study designed to ascertain patient or management factors that increase the risk of developing PPP, with the objective of designing a predictive model to identify high risk PPP candidates. PPP will be defined as pain at the surgical site 3 months after surgery, with severe pain being defined as 5 or more on a 10-point scale. The project involves recruitment of patients, surveys, medical chart data collection, inclusion criteria, exclusion criteria, sample size, data analysis, and assessment of variables.
- Funding
- Royal Hobart Hospital Research Foundation ($8,634)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Orlikowski C; Bereznicki LRE; Peterson GM; Thompson AJ; Veal FC
- Year
- 2013
- Funding
- Aspen Pharmacare Australia ($1,680)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Chalmers L
- Year
- 2012
- Description
- Brown algal extracts, in particular those containing fucoidan and marine polyphloroglucinols, have been shown to have potential applications in a number of health indications such as pre-diabetes, immunomodulation, cardiovascular disease and inflammation. With advances in technology, fucoidan and marine polyphloroglucinol extracts from brown seaweed can now be produced successfully on a commercial scale. These types of extracts are beginning to become more prevalent as ingredients in western dietary supplement markets. However, for the extracts to successfully enter this market, efficacy, safety and provenance must be proven. With this in mind, the objectives of this PhD project include the following: to establish a generic analytical method that can be used to fingerprint and quantify fucoidan concentrations in solution, serum and urine; to determine the ability of a commercially available fucoidan/polyphloroglucinol extract (Maritech Synergy) to inhibit the uptake of glucose via an acute human study; to assess the effects of Maritech Synergy on health indications including glucose control, insulin sensitivity and pre-diabetes in a human setting; and to further the understanding of fucoidan and its metabolism.
- Funding
- Marinova Pty Ltd ($85,000)
- Scheme
- Clinical Trial
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Patel RP; Bereznicki LRE
- Period
- 2012 - 2014
- Funding
- University of Tasmania ($13,000)
- Scheme
- Grant-Research Enhancement (REGS)
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Chalmers L; Jose MD
- Year
- 2012
- Funding
- Royal Hobart Hospital Research Foundation ($12,545)
- Scheme
- Grant-Research
- Administered By
- University of Tasmania
- Research Team
- Chalmers L; Bereznicki LRE; Peterson GM; Hancock N; Roberts-Thomson P
- Period
- 2012 - 2013
- Funding
- Asthma Foundation of Tasmania ($5,500)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Bereznicki BJ; Bereznicki LRE
- Year
- 2011
- Funding
- Pharmaceutical Society of Australia ($49,075)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Thompson AJ
- Year
- 2011
- Funding
- Aspen Pharmacare Australia ($7,890)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Chalmers L
- Year
- 2011
- Funding
- Pharmaceutical Society of Australia ($10,000)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE
- Year
- 2011
- Funding
- University of Tasmania ($22,401)
- Scheme
- Grant-Institutional Research Scheme
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Year
- 2011
- Funding
- Royal Hobart Hospital Research Foundation ($4,545)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Hansen EC; Mirkazemi C
- Year
- 2011
- Funding
- Royal Hobart Hospital Research Foundation ($4,545)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Vonna A; Chalmers L; van Tienen EC; Roberts-Thomson P; Piatkov I
- Year
- 2011
- Funding
- Roche Diagnostics Australia Pty Limited ($57,299)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Year
- 2010
- Funding
- Pharmacy Guild Australia ($148,660)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Clifford R; Gudka S
- Year
- 2010
- Funding
- Pharmaceutical Society of Australia ($3,000)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Thompson AJ
- Year
- 2010
- Funding
- Pharmaceutical Society of Australia ($33,728)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki LRE; Bindoff IK; Spiller CJ
- Year
- 2010
- Funding
- Commonwealth Department of Veterans Affairs ($31,779)
- Scheme
- Grant-Applied Research Program
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Stafford AC; van Tienen EC
- Year
- 2010
- Funding
- University of Tasmania ($17,980)
- Scheme
- Grant-Institutional Research Scheme
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Year
- 2010
- Funding
- University of Tasmania ($74,124)
- Scheme
- Grant-Rising Stars Round 2
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Period
- 2010 - 2012
- Funding
- Pharmaceutical Society of Australia, Tasmanian Branch ($6,415)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Year
- 2009
- Funding
- Roche Diagnostics Australia Pty Limited ($25,000)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Year
- 2009
- Funding
- Department of Health and Aged Care ($19,125)
- Scheme
- Grant-Small Projects Scheme
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; van Tienen EC; Peterson GM
- Period
- 2009 - 2010
- Funding
- Department of Health and Aged Care ($19,735)
- Scheme
- Grant-Small Projects Scheme
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Law KA; Jackson SL; Fitzmaurice KD; Bereznicki LRE; Sutherland P; Howarth H
- Year
- 2009
- Funding
- Department of Health and Aged Care ($198,603)
- Scheme
- Grant-PGA Pharmacy Guild-Investigator Initiated
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Peterson GM; Jackson SL; McLachlan AJ; Bajorek BV; Nelson MR; Marsden KA; Kelly B; Fitzmaurice KD; Gee PR
- Period
- 2008 - 2009
- Funding
- Department of Health and Aged Care ($1,236,174)
- Scheme
- Tender-Warfarin
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Jackson SL; Bereznicki LRE; Nelson MR; Angley M; Mullan J; Gaetini L; Misan G
- Period
- 2008 - 2010
- Funding
- Department of Health and Aged Care ($3,248,448)
- Scheme
- Tender
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Tenni PC; Bereznicki LRE; Jackson SL; Kong D; Hughes J
- Period
- 2008 - 2010
- Funding
- Department of Health and Aged Care ($1,246,926)
- Scheme
- Tender
- Administered By
- Monash University
- Research Team
- Stewart K; George J; Jackson SL; Peterson GM; Hughes J; McNamara K; Bailey M; Hsueh A; McDowell J; Bereznicki LRE; Gee PR
- Period
- 2008 - 2010
- Funding
- Pharmaceutical Society of Australia ($10,000)
- Scheme
- Donation - Institutional
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE
- Period
- 2007 - 2009
- Funding
- Sanofi~Synthelabo Australia Pty Ltd ($30,000)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Jackson SL; Bereznicki LRE
- Year
- 2006
- Funding
- Department of Health and Human Services Tasmania ($199,000)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Jackson SL; Bereznicki LRE
- Period
- 2006 - 2007
Research Supervision
Completed
18
Completed
| Degree | Title | Completed |
|---|---|---|
| PhD | Recurrent Adverse Drug Reaction-related Hospital Admissions: Prevalence, patients, predictors and presentations Candidate: Olive Margaret Schmid | 2023 |
| PhD | Partnered Pharmacist Medication Charting: Evaluation of a process change Candidate: Tesfay Mehari Atey | 2023 |
| PhD | Improving Knowledge and Early Detection of Atrial Fibrillation through Community-Based Opportunistic Screening and Educational Interventions in Tasmania Candidate: Ibrahim Jatau Abubakar | 2021 |
| PhD | Adverse Drug Reaction-related Hospitalisation in Ethiopia Candidate: Mulugeta Tarekegn Angamo | 2018 |
| PhD | The Tasmanian Atrial Fibrillation Study: Transition to direct oral anticoagulants Candidate: Endalkachew Admassie Alamneh | 2018 |
| PhD | Assessment of Anticoagulation Knowledge and Adherence in Patients with Atrial Fibrillation Candidate: Kehinde Olufemi Obamiro | 2018 |
| PhD | Hospitalisation in Older Patients due to Adverse Drug Reactions Candidate: Nibu Parameswaran Nair | 2018 |
| PhD | Early Detection and Prevention of Chronic Kidney Disease Candidate: Pankti Ajay Shastri | 2018 |
| PhD | A Randomised Controlled Trial of Home Medicines Reviews Following Acute Coronary Syndromes Candidate: Daniel David Lewis Bernal | 2017 |
| Masters | Exploring the Potential for Pharmacist Participation in Community-Based Palliative Care Services in North West Tasmania Candidate: Johnny Sieu Kiing Hii | 2017 |
| PhD | Medication Use in Patients with Chronic Kidney Disease Candidate: Aarati Khanal | 2016 |
| PhD | The Pharmacological Management of Pain in Older Australians Candidate: Felicity Claire Veal | 2016 |
| PhD | Antithrombotic Therapy in Patients with Atrial Fibrillation: The Tasmanian experience Candidate: Durga Bista | 2016 |
| PhD | Antiretroviral Adherence and Treatment Outcomes Among Adult Ethiopian Patients Candidate: Woldesellassie Mequanint Bezabhe | 2016 |
| PhD | Thromboprophylaxis Following Hip and Knee Arthroplasty Candidate: Corinne Mirkazemi | 2013 |
| Masters | The Outcomes of Clopidogrel Therapy in Patients with ACS in Southern Tasmania Candidate: Azizah Vonna | 2013 |
| PhD | Optimising Warfarin Management: An Exploration of Pharmacist-delivered Models of Care Candidate: Ella Claire van Tienen | 2012 |
| PhD | The Role of Community Pharmacy in Post-Discharge Warfarin Management Candidate: Leanne Chalmers | 2012 |